<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="pmc-domain-id">1692</journal-id><journal-id journal-id-type="pmc-domain">nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430654</article-id><article-id pub-id-type="pmcid-ver">PMC12430654.1</article-id><article-id pub-id-type="pmcaid">12430654</article-id><article-id pub-id-type="pmcaiid">12430654</article-id><article-id pub-id-type="doi">10.3390/nu17172720</article-id><article-id pub-id-type="publisher-id">nutrients-17-02720</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Nutritional Management in Chronic Pancreatitis: From Exocrine Pancreatic Insufficiency to Precision Therapy</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-0895-1225</contrib-id><name name-style="western"><surname>Bruni</surname><given-names initials="A">Angelo</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref><xref rid="fn1-nutrients-17-02720" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0217-8780</contrib-id><name name-style="western"><surname>Colecchia</surname><given-names initials="L">Luigi</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref><xref rid="fn1-nutrients-17-02720" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9395-5468</contrib-id><name name-style="western"><surname>Dell&#8217;Anna</surname><given-names initials="G">Giuseppe</given-names></name><xref rid="af3-nutrients-17-02720" ref-type="aff">3</xref><xref rid="af4-nutrients-17-02720" ref-type="aff">4</xref><xref rid="af5-nutrients-17-02720" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-7051-5432</contrib-id><name name-style="western"><surname>Scalvini</surname><given-names initials="D">Davide</given-names></name><xref rid="af6-nutrients-17-02720" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9931-7221</contrib-id><name name-style="western"><surname>Mandarino</surname><given-names initials="FV">Francesco Vito</given-names></name><xref rid="af3-nutrients-17-02720" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7724-7402</contrib-id><name name-style="western"><surname>Lisotti</surname><given-names initials="A">Andrea</given-names></name><xref rid="af7-nutrients-17-02720" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fuccio</surname><given-names initials="L">Lorenzo</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1870-5952</contrib-id><name name-style="western"><surname>Cecinato</surname><given-names initials="P">Paolo</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7167-8773</contrib-id><name name-style="western"><surname>Marasco</surname><given-names initials="G">Giovanni</given-names></name><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Donatelli</surname><given-names initials="G">Gianfranco</given-names></name><xref rid="af5-nutrients-17-02720" ref-type="aff">5</xref><xref rid="af8-nutrients-17-02720" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barbara</surname><given-names initials="G">Giovanni</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3323-7744</contrib-id><name name-style="western"><surname>Eusebi</surname><given-names initials="LH">Leonardo Henry</given-names></name><xref rid="af1-nutrients-17-02720" ref-type="aff">1</xref><xref rid="af2-nutrients-17-02720" ref-type="aff">2</xref><xref rid="c1-nutrients-17-02720" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Matsuo</surname><given-names initials="Y">Yoichi</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-nutrients-17-02720"><label>1</label>Gastroenterology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy; <email>angelo.bruni4@unibo.it</email> (A.B.); <email>luigi.colecchia@studio.unibo.it</email> (L.C.); <email>lorenzo.fuccio3@unibo.it</email> (L.F.); <email>paolo.cecinato@aosp.bo.it</email> (P.C.); <email>giovanni.barbara@unibo.it</email> (G.B.)</aff><aff id="af2-nutrients-17-02720"><label>2</label>Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy; <email>giovanni.marasco4@unibo.it</email></aff><aff id="af3-nutrients-17-02720"><label>3</label>Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy; <email>dellanna.giuseppe@hsr.it</email> (G.D.); <email>mandarino.francesco@hsr.it</email> (F.V.M.)</aff><aff id="af4-nutrients-17-02720"><label>4</label>Gastroenterology and Gastrointestinal Endoscopy Unit, IRCCS Policlinico San Donato, Piazza Edmondo Malan 2, 20097 San Donato Milanese, Italy</aff><aff id="af5-nutrients-17-02720"><label>5</label>Unit&#233; d&#8217;Endoscopie Interventionnelle, H&#244;pital Priv&#233; des Peupliers, 75013 Paris, France; <email>gianfranco.donatelli@unina.it</email></aff><aff id="af6-nutrients-17-02720"><label>6</label>Pavia-Gastroenterology and Digestive Endoscopy Unit, Department of Internal Medicine and Therapeutics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy; <email>davide.scalvini01@universitadipavia.it</email></aff><aff id="af7-nutrients-17-02720"><label>7</label>Gastroenterology Unit, Hospital of Imola, University of Bologna, 40026 Bologna, Italy; <email>lisotti.andrea@gmail.com</email></aff><aff id="af8-nutrients-17-02720"><label>8</label>Department of Clinical Medicine and Surgery, University of Naples &#8220;Federico II&#8221;, 80138 Naples, Italy</aff><author-notes><corresp id="c1-nutrients-17-02720"><label>*</label>Correspondence: <email>leonardo.eusebi@unibo.it</email></corresp><fn id="fn1-nutrients-17-02720"><label>&#8224;</label><p>The two authors equally contributed and share first authorship.</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>17</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">495755</issue-id><elocation-id>2720</elocation-id><history><date date-type="received"><day>30</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>18</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nutrients-17-02720.pdf"/><abstract><p>Chronic pancreatitis (CP) precipitates complex malnutrition through synergistic mechanisms: exocrine pancreatic insufficiency&#8211;driven maldigestion, duodenal or pancreatobiliary strictures limiting nutrient flow, cholestasis impairing micelle formation, alcohol-related anorexia, pain-induced hypophagia, proteolytic catabolism from type 3c diabetes, and a chronic inflammatory milieu that accelerates sarcopenia and bone demineralisation. Consequent calorie&#8211;protein depletion, micronutrient and fat-soluble vitamin deficits, and metabolic derangements markedly amplify morbidity. Pancreatic enzyme replacement therapy (PERT) with targeted micronutrient repletion is foundational; high-protein regimens co-administered with PERT curb muscle loss, and medium-chain triglycerides (MCTs) can augment caloric delivery by bypassing lipase dependence, although their benefit over personalised dietetic counselling is marginal. Optimal dietary fat thresholds and timing of escalation from oral to enteral or parenteral feeding remain unresolved. Comprehensive care also demands alcohol abstinence, effective analgesia and stringent glycaemic control. Serial monitoring&#8212;biochemical indices, densitometry, dual-energy X-ray absorptiometry and imaging-based body-composition metrics&#8212;permits early detection of high-risk patients and precision tailoring of interventions. Intensified multidisciplinary programmes already improve prognostic endpoints and are unveiling biomarkers of nutritional resilience. A structured, evidence-based strategy integrating PERT, macronutrient engineering, micronutrient repletion and metabolic surveillance is essential to mitigate nutrition-related morbidity, enhance long-term outcomes and optimise quality of life in CP.</p></abstract><kwd-group><kwd>exocrine pancreatic insufficiency</kwd><kwd>chronic pancreatitis</kwd><kwd>pancreatic enzyme replacement therapy</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-nutrients-17-02720"><title>1. Introduction</title><p>Chronic pancreatitis (CP) is now framed as a progressive fibro-inflammatory syndrome of the pancreas driven by a multifactorial interplay between toxic-metabolic, environmental, and genetic factors (<xref rid="nutrients-17-02720-t001" ref-type="table">Table 1</xref>). Repeated acinar-ductal injury provokes irreversible parenchymal fibrosis and calcification, ductal distortion, and eventual loss of both exocrine and endocrine function, with pain and complex morphological sequelae. Among its systemic manifestations, malnutrition is both a hallmark and an accelerator of disease progression. Exocrine pancreatic insufficiency (EPI) precipitates steatorrhea and proteolytic failure, while chronic inflammation, hypercatabolism and reduced oral intake synergistically induce calorie&#8211;protein malnutrition, sarcopenia, and specific micronutrient deficits [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>]. Studies applying the Global Leadership Initiative on Malnutrition (GLIM) diagnostic criteria report that approximately half of CP cohorts are affected by malnutrition, highlighting its widespread clinical impact [<xref rid="B2-nutrients-17-02720" ref-type="bibr">2</xref>]. Sarcopenia has emerged as a particularly prevalent and prognostically relevant complication. A 2025 meta-analysis that pooled 16 studies (1398 patients) calculated a sarcopenia prevalence of 39% and a two-fold higher risk versus matched controls [<xref rid="B3-nutrients-17-02720" ref-type="bibr">3</xref>,<xref rid="B4-nutrients-17-02720" ref-type="bibr">4</xref>]. Body-composition loss coexists with skeletal consequences: pooled data show osteoporosis in 24% and osteopathy (osteopenia + osteoporosis) in 65% of patients. Underweight status, present in about one-quarter of outpatients, independently correlates with reduced quality of life [<xref rid="B5-nutrients-17-02720" ref-type="bibr">5</xref>].</p><p>Therapeutically, pancreatic enzyme replacement therapy (PERT) remains the pillar for restoring intraluminal digestion and mitigating fat-soluble vitamin depletion. Guideline-driven studies demonstrate that adequate dosing of enteric-coated pancrelipase normalises the coefficient of fat absorption and improves biochemical nutrition markers. Contemporary nutrition protocols now integrate high-protein (&#8805;1.2 g kg<sup>&#8722;1</sup> day<sup>&#8722;1</sup>) feeding, targeted repletion of vitamins A, D, E and K, calcium and trace elements, and consideration of medium-chain triglycerides for selected steatorrhoea-dominant phenotypes [<xref rid="B6-nutrients-17-02720" ref-type="bibr">6</xref>,<xref rid="B7-nutrients-17-02720" ref-type="bibr">7</xref>]. Advances in computed tomography (CT)- and dual-energy X-ray absorptiometry (DXA)-based body-composition analysis, serum metabolomic panels and faecal elastase-1 profiling permit earlier recognition of patients at nutritional risk and pave the way for &#8220;precision nutrition&#8221; algorithms that individualise caloric targets, enzyme posology and microbiota-modulating adjuvants [<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. The overarching aim is to blunt malnutrition-related morbidity, preserve musculoskeletal integrity and ultimately improve survival and life quality in this chronically debilitated population.</p><p>Globally, CP affects approximately 10 individuals per 100,000 person-years, with a stable male predominance (male-to-female ratio &#8776; 2:1) and epidemiological curves that have trended upwards over the past quinquennium [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>]. In the United States, contemporary estimates place the annual incidence between 5 and 8 per 100,000 and the prevalence at 42&#8211;73 per 100,000; in 2018, the disorder generated more than 37,000 emergency-department visits and held the second-highest 30-day readmission rate among digestive diseases (27%), each readmission costing in excess of 27,000 USD [<xref rid="B10-nutrients-17-02720" ref-type="bibr">10</xref>].</p><p>EPI develops in roughly 20% of patients within five years of diagnosis and approaches 70% after two decades, closely paralleling cumulative parenchymal loss and nicotine exposure [<xref rid="B11-nutrients-17-02720" ref-type="bibr">11</xref>]. Endocrine failure follows a similar temporal gradient; up to one-half of individuals develop pancreatogenic (type 3c) diabetes within ten years, characterised by brittle glycaemic profiles and amplified micro- and macrovascular risk [<xref rid="B12-nutrients-17-02720" ref-type="bibr">12</xref>]. These endocrine&#8211;exocrine derangements underpin the high burden of malnutrition: underweight BMI occurs in 26% of outpatients, and GLIM-defined malnutrition, as noted, afflicts about 50% of cohorts, with direct repercussions on hospitalisation and surgical outcomes.</p><p>Registry data indicate that chronic pancreatitis carries a 4- to 5-fold excess mortality relative to the general population, and the onset of exocrine pancreatic insufficiency further doubles that risk [<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. Alongside persistent pain, patients experience fatigue, muscle weakness, diarrhoea and depression, reported in up to 40%, each undermining dietary intake and metabolic stability. These complications drive frequent, protracted hospitalisations and inflate healthcare costs, whereas rigorous enzyme replacement, high-protein nutritional support and systematic micronutrient monitoring demonstrably cut readmissions, preserve bone mineral density and lower fracture incidence [<xref rid="B13-nutrients-17-02720" ref-type="bibr">13</xref>]. To synthesise current evidence, we performed a narrative, evidence-based review based on a structured search through May 2025, focusing only on adult cohorts and excluding paediatric populations because their growth-related nutritional requirements, diagnostic pathways and weight-based PERT dosing differ substantially. We summarise diagnostic standards for EPI and comprehensive nutritional assessment, emphasising GLIM-based phenotyping, body-composition metrics and bone-health evaluation, and translate these into practice with dietary prescriptions, protein&#8211;energy targets and laboratory-guided micronutrient repletion. We delineate PERT formulations, dosing and titration with explicit response and failure criteria; outline escalation from structured counselling to oral nutritional supplements and enteral nutrition, reserving parenteral support for selected indications; and address adjuncts&#8212;acid suppression, diagnosis and treatment of SIBO and microbiota-directed strategies&#8212;with specific considerations for altered postoperative anatomy and type 3c diabetes; finally, we map precision-nutrition pathways integrating FE-1 stratification, imaging-derived body composition and metabolomic profiling.</p></sec><sec id="sec2-nutrients-17-02720"><title>2. Pathophysiology of Malnutrition in Chronic Pancreatitis</title><p>Malnutrition is a common complication in CP: it arises from multiple overlapping factors, including reduced oral food intake caused by chronic abdominal pain and nausea/vomiting, exocrine and endocrine insufficiency, gastrointestinal dysmotility, diarrhoea, chronic inflammation, and gut microbiota alterations [<xref rid="B14-nutrients-17-02720" ref-type="bibr">14</xref>]. These disturbances combine to limit dietary intake and nutrient processing.</p><p>Reduced secretion of pancreatic enzymes and bicarbonates impairs the digestion of both macronutrients and micronutrients [<xref rid="B12-nutrients-17-02720" ref-type="bibr">12</xref>]. Triglyceride digestion is particularly affected: lipid maldigestion leads to wasting and deficiency of fat-soluble vitamins A, D, E and K [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>]. Protease deficiency in EPI also causes protein-energy malnutrition and can impair vitamin B12 absorption [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>]. This is aggravated by systemic inflammation, since recurrent pancreatic injury leads to the release of pro-inflammatory cytokines (e.g., TNF-&#945;, IL-6) and acute-phase proteins, sustaining a continuous catabolic state, anorexia, increased basal energy expenditure, and proteolysis [<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. Chronic inflammation also disrupts micronutrient metabolism, accelerating bone resorption and depleting vitamin D stores [<xref rid="B15-nutrients-17-02720" ref-type="bibr">15</xref>].</p><p>A further destabilising event, usually in later phases, is endocrine insufficiency due to the loss of Langerhans islet cells, often referred to as pancreatogenic or type 3c diabetes [<xref rid="B16-nutrients-17-02720" ref-type="bibr">16</xref>]. This form of diabetes features deficient insulin and often deficient glucagon, causing weak glycaemic control and hypoglycaemia [<xref rid="B17-nutrients-17-02720" ref-type="bibr">17</xref>]. The lack of insulin shifts metabolism toward gluconeogenesis and further protein lysis, perpetuating catabolism. Glycaemic instability itself may also reduce appetite and increase energy expenditure. Moreover, recurrent postprandial pain and nausea or vomiting, often cause patients to restrict meal size or even skip meals, aggravating calorie deficit [<xref rid="B18-nutrients-17-02720" ref-type="bibr">18</xref>].</p><p>Chronic pancreatitis is also associated with gastrointestinal motility disturbances [<xref rid="B19-nutrients-17-02720" ref-type="bibr">19</xref>]. Chronic pain, type 3c diabetes, and opioid analgesics contribute to gastroparesis and delayed intestinal transit. These motility defects, along with reduced pancreatic synthesis of antimicrobial peptides and reduced chyme alkalisation favour small intestinal bacterial overgrowth (SIBO) [<xref rid="B20-nutrients-17-02720" ref-type="bibr">20</xref>,<xref rid="B21-nutrients-17-02720" ref-type="bibr">21</xref>]. A meta-analysis of nine studies including 336 CP patients found a pooled prevalence of SIBO, mainly diagnosed with glucose or lactulose breath tests, of 36% [95% confidence interval (CI): 17&#8211;60%, with considerable heterogeneity (I<sup>2</sup> 91%)]. Small intestinal bacterial overgrowth worsens malnutrition by consuming nutrients and damaging the brush border, impairing absorption [<xref rid="B22-nutrients-17-02720" ref-type="bibr">22</xref>].</p><p>Refs. [<xref rid="B23-nutrients-17-02720" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-17-02720" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-17-02720" ref-type="bibr">25</xref>] the combined effects of endocrine and exocrine insufficiency, dysmotility, SIBO, chronic inflammation and reduced oral food intake lead to profound nutrient deficiencies. Clinically, vitamin deficiencies can contribute to severe scenarios such as osteopenia/osteoporosis, coagulopathy, night blindness, peripheral neuropathy, and other complications [<xref rid="B6-nutrients-17-02720" ref-type="bibr">6</xref>]. In a recent meta-analysis on 17 studies involving 1659 subjects with CP, the pooled rate of osteoporosis was 18% (95% CI: 12&#8211;23%; <italic toggle="yes">p</italic> &lt; 0.001; I<sup>2</sup> = 86.3%), and the pooled rate of osteopenia was 39% (95% CI: 31&#8211;48%; <italic toggle="yes">p</italic> &lt; 0.001; I<sup>2</sup> = 91.53%), likely due to poor vitamin D/calcium absorption and chronic inflammation limiting bone anabolism [<xref rid="B26-nutrients-17-02720" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-17-02720" ref-type="bibr">27</xref>]. Finally, persistent steatorrhea and weight loss despite enzyme therapy can cause severe malnutrition and sarcopenia, reported in ~39% of patients with CP in a recent meta-analysis on 6 studies with 1556 participants [<xref rid="B4-nutrients-17-02720" ref-type="bibr">4</xref>]. In this context, autoimmune pancreatitis (AIP) merits separate consideration. Type 1 belongs to IgG4-related disease, and type 2 is defined by granulocytic epithelial lesions with a typical absence of systemic IgG4 involvement. Compared with alcohol-related CP, AIP more often presents with painless obstructive jaundice, cholestasis and extra-pancreatic disease, with frequent IgG4 elevation in type 1 and marked steroid responsiveness [<xref rid="B23-nutrients-17-02720" ref-type="bibr">23</xref>]. Glucocorticoids are first line; induction with prednisolone can induce rapid clinical, biochemical and radiologic remission and can obviate prolonged biliary stenting, while early therapy limits progression to fixed exocrine and endocrine failure. Given relapse risk and steroid toxicity, a treat-to-target strategy with close monitoring and maintenance in high-risk phenotypes is recommended; B-cell depletion with rituximab is effective but lacks head-to-head randomised controlled trials versus steroids [<xref rid="B24-nutrients-17-02720" ref-type="bibr">24</xref>]. Similarly to toxic-metabolic forms, EPI and diabetes are frequent at diagnosis, and micronutrient deficits can persist despite pancreatic enzyme replacement therapy. In a cohort of 100 patients, 38% developed at least one deficiency, with zinc in 25.5% and vitamin D in 16.1%, and the odds of any deficiency were increased fivefold in those with exocrine insufficiency (OR 5.1; 95% CI 1.4&#8211;18.8); crude associations with relapse attenuated after adjustment [<xref rid="B25-nutrients-17-02720" ref-type="bibr">25</xref>].</p></sec><sec id="sec3-nutrients-17-02720"><title>3. Diagnosis of Exocrine Pancreatic Insufficiency and Nutritional Assessment</title><sec id="sec3dot1-nutrients-17-02720"><title>3.1. Definition and Pathogenesis</title><p>Exocrine pancreatic insufficiency is defined as a decrease in exocrine pancreatic secretion and/or intraluminal pancreatic enzyme activity below the threshold necessary for normal nutrient digestion [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>]. Consequently, EPI is associated not only with nutrient malabsorption and deficiencies but also with gastrointestinal symptoms, although clinical manifestations are extremely variable due to the role of several factors [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>,<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>]. Insufficient postprandial stimulation of the exocrine pancreas, along with reduced secretion of pancreatic enzymes and bicarbonate due to pancreatic tissue damage, represent the two primary mechanisms underlying EPI [<xref rid="B29-nutrients-17-02720" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-17-02720" ref-type="bibr">30</xref>].</p><p>The pathogenesis of EPI in CP is multifactorial. First, parenchymal atrophy and chronic inflammation result in reduced pancreatic enzyme production. Second, ductal obstruction due to intraductal stones and/or strictures compromises the delivery of enzymes to the duodenal lumen. Third, in patients with genetic forms of CP, alterations in the functional activity of pancreatic enzymes may also play a role. Fourth, altered upper gastrointestinal anatomy following resective or bypass pancreatic surgery may disrupt the coordination between chyme transit and pancreatic enzyme secretion, further contributing to maldigestion [<xref rid="B31-nutrients-17-02720" ref-type="bibr">31</xref>].</p></sec><sec id="sec3dot2-nutrients-17-02720"><title>3.2. Epidemiology</title><p>The lifetime risk of developing EPI in patients with CP is high, with a reported prevalence ranging from 20% to 90%. Data from the Scandinavian Baltic Pancreatic Club (SBPC) database, published in 2017, including 910 CP patients, mostly alcoholic in aetiology, showed a prevalence of EPI of 68%, [<xref rid="B32-nutrients-17-02720" ref-type="bibr">32</xref>]. with other datasets reporting a prevalence of EPI in 60&#8211;90% of patients within ten years of CP diagnosis, with toxic aetiologies, such as chronic alcohol consumption and tobacco use, identified as significant risk factors [<xref rid="B32-nutrients-17-02720" ref-type="bibr">32</xref>].</p><p>This variability is closely related to the duration, aetiology, and severity of the disease [<xref rid="B33-nutrients-17-02720" ref-type="bibr">33</xref>,<xref rid="B34-nutrients-17-02720" ref-type="bibr">34</xref>]. A recent study from the Dutch Chronic Pancreatitis Registry, which included 987 patients with CP and a median disease duration of 83 months (interquartile range (IQR) 41&#8211;158), demonstrated that patients with EPI had significantly longer disease duration [<xref rid="B33-nutrients-17-02720" ref-type="bibr">33</xref>]. Specifically, the median duration was 26 months longer in patients with definite EPI compared to those without EPI (<italic toggle="yes">p</italic> &lt; 0.001). An additional noteworthy finding from the study by Kempeneers et al. is the progressive increase in EPI prevalence over time, rising from 20% after 5 years of disease to 70% after 20 years [<xref rid="B33-nutrients-17-02720" ref-type="bibr">33</xref>]. Additionally, CP aetiology plays a crucial role in the timing of development and severity of EPI. The EPI development is significantly more rapid in exotoxic CP patients (mean 13.1 years) compared to genetic and idiopathic CP (mean 26.3 years) [<xref rid="B35-nutrients-17-02720" ref-type="bibr">35</xref>]. Lastly, the presence of intraductal calcifications was recognised as a significant risk factor for EPI, consequentially increasing the rates of malnutrition [<xref rid="B36-nutrients-17-02720" ref-type="bibr">36</xref>].</p></sec><sec id="sec3dot3-nutrients-17-02720"><title>3.3. Diagnosis</title><p>The diagnosis of EPI requires an integrated approach. Commonly available pancreatic function tests, clinical symptoms, and nutritional deficiencies each have limited specificity. Therefore, EPI should not be diagnosed based on any single diagnostic parameter. Instead, a combined assessment is necessary in each relevant clinical context to ensure accurate diagnosis (<xref rid="nutrients-17-02720-t002" ref-type="table">Table 2</xref>) [<xref rid="B37-nutrients-17-02720" ref-type="bibr">37</xref>,<xref rid="B38-nutrients-17-02720" ref-type="bibr">38</xref>].</p><p>First, clinical evaluation is fundamental. Patients with a history of chronic pancreatitis or pancreatic head cancer, or those who have undergone total pancreatectomy or pancreaticoduodenectomy, and who present with symptoms of malabsorption, have an extremely high pre-test probability of EPI [<xref rid="B29-nutrients-17-02720" ref-type="bibr">29</xref>,<xref rid="B39-nutrients-17-02720" ref-type="bibr">39</xref>,<xref rid="B40-nutrients-17-02720" ref-type="bibr">40</xref>].</p><p>Clinical evaluation includes the examination of symptoms and signs linked to the malabsorption of fat-soluble vitamins (A-D-E-K). These nonspecific manifestations include fatigue, steatorrhea, bloating/abdominal pain, osteoporosis, change in iron metabolism, ecchymosis, impaired night vision, xerophthalmia, ataxia, peripheral neuropathy, and muscle spasms [<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>,<xref rid="B31-nutrients-17-02720" ref-type="bibr">31</xref>,<xref rid="B41-nutrients-17-02720" ref-type="bibr">41</xref>]. In patients with known pancreatic disease, clinically evident steatorrhea and flatulence represent the two most common symptoms, with a frequency that ranges from 15% to 70% and from 55% to 100%, respectively [<xref rid="B42-nutrients-17-02720" ref-type="bibr">42</xref>].</p></sec><sec id="sec3dot4-nutrients-17-02720"><title>3.4. Nutritional Assessment</title><p>Together with clinical evaluation, nutritional assessment plays a pivotal role in the EPI diagnosis in patients with CP. At the time of diagnosis, many CP patients already present with weight loss, often resulting from chronic inflammation, EPI, and associated comorbidities [<xref rid="B43-nutrients-17-02720" ref-type="bibr">43</xref>]. Although screening tools such as the Malnutrition Universal Screening Tool (MUST) and the Nutritional Risk Score (NRS-2002) are commonly recommended, they were not specifically developed for CP and may have limitations in predicting clinically relevant outcomes [<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>,<xref rid="B43-nutrients-17-02720" ref-type="bibr">43</xref>]. For instance, MUST demonstrates high specificity (80%) but low sensitivity (34%) in forecasting hospitalisation risk [<xref rid="B2-nutrients-17-02720" ref-type="bibr">2</xref>,<xref rid="B43-nutrients-17-02720" ref-type="bibr">43</xref>]. More recently, the GLIM has proposed a more comprehensive framework for nutritional assessment, integrating phenotypic criteria (e.g., unintentional weight loss, low BMI, reduced muscle mass) with etiologic factors such as inflammation or malabsorption [<xref rid="B44-nutrients-17-02720" ref-type="bibr">44</xref>,<xref rid="B45-nutrients-17-02720" ref-type="bibr">45</xref>].</p><p>Another fundamental aspect of a correct nutritional assessment is the evaluation of sarcopenia. CT is frequently used to assess muscle mass in CP patients and has suggested a sarcopenia prevalence of approximately 30&#8211;40%, though standardised thresholds and functional correlates remain unclear [<xref rid="B46-nutrients-17-02720" ref-type="bibr">46</xref>]. Alternatively, bioelectrical impedance analysis (BIA) offers a practical and noninvasive method for evaluating body composition. In particular, the phase angle (PhA), derived from BIA, has shown prognostic value across several chronic diseases and correlates with muscle status and inflammatory burden [<xref rid="B47-nutrients-17-02720" ref-type="bibr">47</xref>]. However, data on its application in CP is still limited. In their study, Olesen et al. evaluated 184 patients with chronic pancreatitis using BIA. Sarcopenia was identified in 17% of cases, the majority of whom had a normal BMI [<xref rid="B48-nutrients-17-02720" ref-type="bibr">48</xref>]. In a more recent multicentre study, Wiese et al. assessed 66 CP patients using both BIA and handgrip strength measurements. Over 60% of patients showed signs of malnutrition; however, handgrip strength was not associated with malnutrition but only with muscle mass. The proportion of patients presenting both reduced muscle mass and decreased handgrip strength was limited to just 3% [<xref rid="B45-nutrients-17-02720" ref-type="bibr">45</xref>].</p><p>Adequate bone health checks are critical during patients&#8217; evaluations. In fact, bone disease, including osteopenia and osteoporosis, is a frequent and often underrecognised complication [<xref rid="B9-nutrients-17-02720" ref-type="bibr">9</xref>,<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>,<xref rid="B49-nutrients-17-02720" ref-type="bibr">49</xref>]. Several patient-related factors have been associated with low bone mineral density (BMD), including advanced age, female sex, smoking, alcohol consumption, low BMI, and nutritional deficiencies. Fat-soluble vitamin deficiencies, especially vitamins D and K, are common in CP and play a crucial role in bone metabolism, linking EPI and malabsorption to skeletal fragility. Accordingly, the fracture risk in CP is significantly increased, reaching 6% in some cohorts, with a predominance of low-impact fractures involving the hip, vertebral bodies, and distal radius [<xref rid="B49-nutrients-17-02720" ref-type="bibr">49</xref>]. Despite the clinical relevance, only about one in four patients undergoes appropriate bone health screening, suggesting that bone complications remain an underestimated source of morbidity [<xref rid="B49-nutrients-17-02720" ref-type="bibr">49</xref>].</p><p>However, data comparing vitamin D levels between CP patients and healthy controls are inconsistent. Hoogenboom et al. and Duggan et al. both reported high rates of vitamin D deficiency in CP, but without significant differences from control groups [<xref rid="B50-nutrients-17-02720" ref-type="bibr">50</xref>,<xref rid="B51-nutrients-17-02720" ref-type="bibr">51</xref>]. Conversely, another study found that a significantly larger proportion of CP patients had serum vitamin D levels below 30 ng/mL compared to controls [<xref rid="B52-nutrients-17-02720" ref-type="bibr">52</xref>]. Inconsistencies across studies may stem from heterogeneity in study populations, lack of standardisation in laboratory assays, seasonal variation in sun exposure, and the role of vitamin D as a negative acute-phase reactant [<xref rid="B53-nutrients-17-02720" ref-type="bibr">53</xref>].</p><p>Considering these findings, guidelines recommend baseline assessment of fat-soluble vitamin levels and BMD via DXA in all CP patients, with repeat evaluations every two years in those with osteopenia [<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>,<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>,<xref rid="B54-nutrients-17-02720" ref-type="bibr">54</xref>]. Referral to a bone specialist is advised in cases of osteoporosis for appropriate pharmacologic intervention. Nonetheless, real-world adherence to these recommendations remains low, and high-quality evidence on the impact of PERT or bone-specific therapies on fracture prevention in CP is still lacking [<xref rid="B55-nutrients-17-02720" ref-type="bibr">55</xref>].</p><p>Alternative testing tools are under investigation. A pilot study by Baltar et al. proposed the use of opportunistic CT scan assessment as a viable method for osteoporosis screening in CP patients, especially when CT imaging is already available for other indications [<xref rid="B56-nutrients-17-02720" ref-type="bibr">56</xref>]. Biochemical markers of bone turnover also appear altered in CP. In one study, levels of procollagen type I N-terminal propeptide (PINP) and osteocalcin were higher in CP patients compared to controls. Patients with vitamin D levels below 20 ng/mL showed significantly increased PINP concentrations, suggesting an imbalance in bone remodelling [<xref rid="B52-nutrients-17-02720" ref-type="bibr">52</xref>].</p></sec><sec id="sec3dot5-nutrients-17-02720"><title>3.5. Pancreatic Function Tests</title><p>A range of diagnostic modalities is available to assess exocrine pancreatic function, although each has specific limitations in terms of accuracy, availability, or practicality [<xref rid="B57-nutrients-17-02720" ref-type="bibr">57</xref>]. Direct pancreatic function tests&#8212;such as the aspiration of duodenal fluid following hormonal stimulation with secretin, cholecystokinin, or cerulein&#8212;provide detailed information on pancreatic secretory capacity. However, these procedures are invasive, time-consuming, and primarily reserved for research settings or specialised centres due to their complexity and low accessibility [<xref rid="B31-nutrients-17-02720" ref-type="bibr">31</xref>].</p><p>Among the indirect methods, the quantitative measurement of faecal fat with calculation of the coefficient of fat absorption (CFA) has traditionally been regarded as a gold standard for assessing steatorrhea. This test involves adherence to a high-fat diet followed by a 72 h stool collection, making it cumbersome and largely impractical in routine clinical care. The 13C-mixed triglyceride breath test offers a less invasive alternative by quantifying labelled carbon dioxide in exhaled air after ingestion of a 13C-labelled triglyceride substrate. It reflects the combined processes of lipolysis, absorption, and oxidation of dietary fat, and it has the additional benefit of allowing for dynamic monitoring of PERT efficacy [<xref rid="B58-nutrients-17-02720" ref-type="bibr">58</xref>]. Nevertheless, its limited availability and lack of standardisation have restricted its widespread clinical adoption.</p><p>In current practice, faecal elastase-1 (FE-1) measurement is the most used non-invasive test for diagnosing EPI [<xref rid="B59-nutrients-17-02720" ref-type="bibr">59</xref>]. FE-1 is stable in stool and unaffected by pancreatic enzyme supplementation, making it convenient for outpatient use. A threshold of 200 &#956;g/g is widely accepted as the normal cutoff; values between 100 and 200 &#956;g/g are considered indeterminate or suggestive of mild-to-moderate insufficiency, whereas concentrations below 100 &#956;g/g are highly specific for moderate-to-severe EPI. A meta-analysis comparing FE-1 with faecal fat quantification reported a sensitivity of 96% and specificity of 88%, underscoring its diagnostic reliability, particularly for more advanced cases of EPI [<xref rid="B38-nutrients-17-02720" ref-type="bibr">38</xref>].</p><p>A key pitfall of FE-1 testing is that it may not accurately detect mild or moderate exocrine pancreatic insufficiency; thus, FE-1 is not useful for early-stage chronic pancreatitis patients. Moreover, the test results can be affected by stool consistency, so watery or diluted stool samples may lead to inaccurate results and false positive diagnoses of EPI. Finally, patients with upper gastrointestinal anatomy alterations (such as in the case of gastrectomy) could present normal FE-1 values but present with exocrine pancreatic insufficiency.</p></sec></sec><sec id="sec4-nutrients-17-02720"><title>4. Dietary Management</title><sec id="sec4dot1-nutrients-17-02720"><title>4.1. General Dietary Indications</title><p>Nutritional goals include preserving body weight and lean mass, preventing micronutrient deficiencies, optimising glycaemic control, and minimising pain-related eating restrictions [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. According to the international guidelines, patients with CP without nutritional deficits should follow a balanced diet and do not need to follow a restrictive diet [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>,<xref rid="B60-nutrients-17-02720" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-17-02720" ref-type="bibr">61</xref>,<xref rid="B62-nutrients-17-02720" ref-type="bibr">62</xref>]. It should be noted, however, that no clinical trials are available comparing the short- and long-term outcomes of dietary changes versus a balanced diet in this specific setting; therefore, the quality of evidence is low.</p><p>Strict long-term fat restriction is no longer universally advocated. There is no high-quality evidence that a very-low-fat diet improves pancreatitis outcomes, and unnecessary restriction can worsen an already fragile nutritional status [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B63-nutrients-17-02720" ref-type="bibr">63</xref>,<xref rid="B64-nutrients-17-02720" ref-type="bibr">64</xref>]. Nonetheless, there is little consensus on the management of diet in patients without nutritional deficits in whom significant pain is present after meals. In fact, abdominal pain in CP is often triggered by food intake that stimulates pancreatic secretion. General dietary strategies in this case include a tailored approach: during acute flares or in pain-prone individuals, moderate fat reduction for a limited time may be tried with the aim of reducing excessive cholecystokinin (CCK) release and avoiding pancreatic secretion. In all cases, patients should avoid binge eating or prolonged fasting, and in case of the failure of traditional advice, peptide-based enteral formulas rich in medium-chain triglycerides (MCTs) or even elemental diets may be tried [<xref rid="B65-nutrients-17-02720" ref-type="bibr">65</xref>,<xref rid="B66-nutrients-17-02720" ref-type="bibr">66</xref>,<xref rid="B67-nutrients-17-02720" ref-type="bibr">67</xref>]. Strong consensus is present internationally on the importance of complete abstinence from alcohol and smoking, as they are considered among the most important risk factors and pain triggers in CP.</p></sec><sec id="sec4dot2-nutrients-17-02720"><title>4.2. Dietary Indications for Patients with Malnutrition</title><p>General nutritional advice from international guidelines for malnourished patients with CP is to consume high-protein, high-energy food in five to six small meals per day. (<xref rid="nutrients-17-02720-t003" ref-type="table">Table 3</xref>) In order to reduce the risk of hypoglycaemia, especially in patients with type 3c diabetes, patients should avoid skipping meals [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. No specific recommendation is given on the daily dosage of macronutrients [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>]. However, as patients typically have increased resting energy expenditure of approximately ~30&#8211;35 kcal/kg/day to offset hypermetabolism, this could be a reasonable starting point for dietary counselling [<xref rid="B63-nutrients-17-02720" ref-type="bibr">63</xref>]. In order to reach a high intake of foods with limited fat intake, significant protein intake (~1.2&#8211;1.5 g/kg/day; consisting of meat, fish, eggs and legumes) and a high-carbohydrate diet (whole grains and legumes) are advised to support lean tissue [<xref rid="B68-nutrients-17-02720" ref-type="bibr">68</xref>]. Fat intake may be tolerated at ~25&#8211;35% of total calories if pancreatic enzyme replacement is optimised rather than enforcing a strict low-fat diet [<xref rid="B69-nutrients-17-02720" ref-type="bibr">69</xref>]. In both patients with and without EPI, fibre and meal volume require consideration. Even though the recommendation is based on a few dated studies, a very high-fibre diet may bind nutrients and worsen steatorrhea; therefore, fibre should be kept at a moderate level, especially if enzyme dosing is suboptimal [<xref rid="B70-nutrients-17-02720" ref-type="bibr">70</xref>].</p></sec><sec id="sec4dot3-nutrients-17-02720"><title>4.3. Micronutrient Supplementation</title><p>In CP, intraluminal maldigestion and malabsorption&#8212;driven by EPI, an acidic duodenal environment, bile-acid dysmetabolism and small-bowel dysbiosis&#8212;produce deficits in fat-soluble vitamins (A, D, E, K), water-soluble vitamins (B12, folate, thiamine) and key minerals such as calcium, magnesium and zinc [<xref rid="B51-nutrients-17-02720" ref-type="bibr">51</xref>,<xref rid="B71-nutrients-17-02720" ref-type="bibr">71</xref>,<xref rid="B72-nutrients-17-02720" ref-type="bibr">72</xref>,<xref rid="B73-nutrients-17-02720" ref-type="bibr">73</xref>]. Guidelines uniformly recommend routine monitoring and replacement of these nutrients. Patients should have periodic lab assessments of 25-OH vitamin D, vitamins A and E, and coagulation profiles [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>,<xref rid="B60-nutrients-17-02720" ref-type="bibr">60</xref>,<xref rid="B61-nutrients-17-02720" ref-type="bibr">61</xref>,<xref rid="B65-nutrients-17-02720" ref-type="bibr">65</xref>,<xref rid="B74-nutrients-17-02720" ref-type="bibr">74</xref>]. Notably, both Japanese and European guidelines advise against blind supplementation of all fat-soluble vitamins for all patients with CPs and suggest supplementing vitamins A, D, E, and K once EPI is present [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B65-nutrients-17-02720" ref-type="bibr">65</xref>]. Although water-soluble vitamin deficiency may be present, it should be noted that it is much rarer. In fact, in recent case&#8211;control studies between patients with CP and controls, no statistical difference in water-soluble vitamin deficiency was noted [<xref rid="B73-nutrients-17-02720" ref-type="bibr">73</xref>,<xref rid="B75-nutrients-17-02720" ref-type="bibr">75</xref>]. Regardless, it is still recommended to routinely test and treat for vitamin B12, folic acid and thiamine deficiency, especially in patients with alcohol use disorder [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B8-nutrients-17-02720" ref-type="bibr">8</xref>].</p></sec><sec id="sec4dot4-nutrients-17-02720"><title>4.4. The Role of Multidisciplinary Teams and Psycho-Social Counselling</title><p>Further general recommendations on nutrition in CP include patients&#8217; and caregivers&#8217; education on diet, adequate symptom monitoring and aid in quitting alcohol and tobacco. Meal diaries or written dietary regimens might assist patients in monitoring their consumption and symptoms [<xref rid="B76-nutrients-17-02720" ref-type="bibr">76</xref>]. A pancreatic disease-experienced dietitian who can modify dietary objectives, customise meal planning, and suggest oral supplements should be part of the treatment team [<xref rid="B64-nutrients-17-02720" ref-type="bibr">64</xref>,<xref rid="B77-nutrients-17-02720" ref-type="bibr">77</xref>,<xref rid="B78-nutrients-17-02720" ref-type="bibr">78</xref>].</p><p>Lastly, CP is linked to a high disease burden, a substantial detrimental influence on quality of life and elevated rates of anxiety and depression. These conditions can diminish appetite, lead to emotional eating or avoidance of eating due to fear of pain and impair adherence to dietary regimens. For these reasons present-day viewpoints on CP treatment have changed to support a multidisciplinary strategy that provides psychological aid to help people cope with pain and adjust to chronic disease and social instances [<xref rid="B79-nutrients-17-02720" ref-type="bibr">79</xref>]. Therefore, clinicians should screen for depression and anxiety and recognise their impact on nutrition. Behavioural interventions such as relaxation techniques, mindfulness or group support may reduce pain perception and facilitate normal eating patterns and should be a fundamental aid to analgesic pharmacological therapy [<xref rid="B79-nutrients-17-02720" ref-type="bibr">79</xref>]. These concepts underscore the need for a multidisciplinary team composed of general practitioners, gastroenterologists, dieticians, endocrinologists, psychiatrists, and psychologists.</p></sec></sec><sec id="sec5-nutrients-17-02720"><title>5. Principles of Pancreatic Enzyme Replacement Therapy</title><p>PERT is a cornerstone in the management of CP when there is a concomitant EPI. Its primary goal is to restore adequate digestion, to improve nutrient absorption and decrease gastrointestinal symptoms. As a matter of fact, the maldigestion of lipids is the main cause of malnutrition and underlies key gastrointestinal manifestations occurring during CP, such as steatorrhea, weight loss, bloating, and abdominal discomfort. While the human body has other compensatory mechanisms for metabolisation of proteins and carbohydrates, the pancreas is the only one responsible for lipid digestion, making lipase replacement the central focus of PERT.</p><p>PERT is administered orally, mainly through pH-dependent enteric-coated microspheres or capsules that carry amylase, lipase, and protease to compensate for CP enzymatic deficiencies. These formulations are designed to resist gastric acidity and release their enzymatic content in the small intestine at a pH &#8805; 5.5. In the case of non-enteric-coated formulations, the administration of a proton pump inhibitor is required to maximise their effectiveness [<xref rid="B80-nutrients-17-02720" ref-type="bibr">80</xref>]. All currently approved drugs are porcine-derived, and no synthetic or human-derived enzyme formulations are available. These products differ in their enzyme ratios (lipase, amylase, and protease) and inactive ingredients and are labelled according to their lipase activity [<xref rid="B81-nutrients-17-02720" ref-type="bibr">81</xref>]. To date, there is no head-to-head randomised controlled trial (RCT) comparing the effect of different products for EPI in CP. The only direct comparison comes from studies in cystic fibrosis-related EPI, where no significant differences in CFA were observed between two commonly prescribed formulations [<xref rid="B82-nutrients-17-02720" ref-type="bibr">82</xref>].</p><p>In CP-related EPI, PERT should be taken with every lipid-containing meal or snack, starting with the first bites and repeated mid-meal to optimise intraluminal mixing and lipolysis. Dosing is individualised to meal fat load, EPI severity and gastrointestinal anatomy; a pragmatic adult starting regimen is 40,000&#8211;50,000 U lipase with main meals and ~20,000&#8211;25,000 U with snacks, with stepwise titration to clinical response&#8212;resolution of steatorrhoea, normalisation of stool form and frequency, weight stabilisation, and correction of fat-soluble vitamin deficits [<xref rid="B80-nutrients-17-02720" ref-type="bibr">80</xref>]. Head-to-head RCTs among pancrelipase formulations in adult CP are lacking; current practice therefore rests on a class effect and limited extrapolation from CF, where approved products show no clinically meaningful differences. In refractory steatorrhoea despite adherence, escalation to 75,000&#8211;100,000 U lipase per meal is reasonable, coupled with a structured review of modifiable factors (dietary fat and excess fibre, SIBO and glycaemic instability).</p><p>Acid suppression with a PPI can be trialled when low intraduodenal pH is suspected (e.g., rapid gastric emptying, postsurgical anatomy) or when clinical targets are unmet on adequate dosing; however, evidence for an additive effect of PPIs is mixed&#8212;small randomised and physiological studies in CF-EPI have not demonstrated consistent improvements in fat absorption Refs. [<xref rid="B83-nutrients-17-02720" ref-type="bibr">83</xref>,<xref rid="B84-nutrients-17-02720" ref-type="bibr">84</xref>]&#8212;so PPI co-therapy should be time-limited and continued only if predefined endpoints are achieved [<xref rid="B85-nutrients-17-02720" ref-type="bibr">85</xref>,<xref rid="B86-nutrients-17-02720" ref-type="bibr">86</xref>,<xref rid="B87-nutrients-17-02720" ref-type="bibr">87</xref>,<xref rid="B88-nutrients-17-02720" ref-type="bibr">88</xref>]. In altered postoperative anatomy, microgranular enteric-coated preparations &lt;2 mm that co-empty with chyme, meticulous dose splitting and routine PPI co-therapy are preferred.</p><p>The efficacy of PERT is most assessed in clinical trials using CFA as the primary endpoint, and all the PERT bring improvements in CFA levels, stool frequency and quality of life compared to placebo [<xref rid="B89-nutrients-17-02720" ref-type="bibr">89</xref>]. On the contrary, improvements in nutritional parameters such as fat-soluble vitamins, albumin, prealbumin and haemoglobin yielded inconsistent results across studies. Replacement therapy is generally well tolerated, but a few studies reported adverse events such as nausea and constipation related to higher doses [<xref rid="B90-nutrients-17-02720" ref-type="bibr">90</xref>].</p></sec><sec id="sec6-nutrients-17-02720"><title>6. Adjuvant and Emerging Therapies</title><sec id="sec6dot1-nutrients-17-02720"><title>6.1. Beyond Standard Nutritional Advice</title><p>The majority of patients with CP complicated by malnutrition can be effectively managed with dietary advice and PERT. However, typically 10&#8211;15% of patients do not reach preset dietary goals and require further therapy such as oral nutrition supplementation (ONS) or enteral or parenteral feeding. Enteral formulae consisting of pre-digested products and a mixture of long-chain fatty acids (LCFAs) and MCTs have been proposed as therapeutic solutions [<xref rid="B64-nutrients-17-02720" ref-type="bibr">64</xref>,<xref rid="B91-nutrients-17-02720" ref-type="bibr">91</xref>]. However, MCTs yield less energy when compared to LCFAs and are often associated with adverse effects like cramps, nausea, and diarrhoea [<xref rid="B91-nutrients-17-02720" ref-type="bibr">91</xref>]. Up to now, studies have have not demonstrated any clear benefit of MCTs over LCFAs when used in combination with enzyme supplementation or over adequate dietary counselling [<xref rid="B76-nutrients-17-02720" ref-type="bibr">76</xref>,<xref rid="B91-nutrients-17-02720" ref-type="bibr">91</xref>].</p><p>If oral intake is insufficient or gastrointestinal symptoms prevent adequate nutrition, enteral nutrition (EN) is recommended. Naso-gastric tube-feeding (or naso-jejunal if gastric outlet syndrome symptoms or gastroparesis are present) is generally well tolerated and can improve weight gain and pain control and reduce analgesic requirements [<xref rid="B1-nutrients-17-02720" ref-type="bibr">1</xref>,<xref rid="B6-nutrients-17-02720" ref-type="bibr">6</xref>,<xref rid="B64-nutrients-17-02720" ref-type="bibr">64</xref>,<xref rid="B92-nutrients-17-02720" ref-type="bibr">92</xref>,<xref rid="B93-nutrients-17-02720" ref-type="bibr">93</xref>]. If long-term support (&gt;4&#8211;6 weeks) is needed, a gastrojejunostomy tube may be placed to reduce patients&#8217; discomfort. Although no comparative studies have been performed on the matter, it is reasonable in these cases to start with standard (polymeric, whole-protein) formulas and to use peptide-based or even elemental formulas in case of intolerance.</p><p>The last resort to maintain an adequate daily energy intake in case of failure of all previous therapies or rare situations such as duodenal obstruction, complex fistulae or perioperative nutrition in severely malnourished patients is parenteral nutrition (PN) (&lt;1% of cases) [<xref rid="B94-nutrients-17-02720" ref-type="bibr">94</xref>]. In the case of PN, central line positioning is recommended along with vigilant control of potential infectious and hepatologic complications.</p></sec><sec id="sec6dot2-nutrients-17-02720"><title>6.2. Gut&#8211;Pancreas Axis</title><p>The gut&#8211;pancreas axis is an emerging target in CP. As previously described, CP patients often have SIBO, which may worsen malnutrition and inflammation and can be a treatment target [<xref rid="B21-nutrients-17-02720" ref-type="bibr">21</xref>,<xref rid="B95-nutrients-17-02720" ref-type="bibr">95</xref>,<xref rid="B96-nutrients-17-02720" ref-type="bibr">96</xref>]. The cornerstone of SIBO&#8217;s treatment, once a diagnosis based on symptoms and an indicative hydrogen or lactulose test has been made, is antibiotic therapy [<xref rid="B97-nutrients-17-02720" ref-type="bibr">97</xref>]. No trials have been performed yet on antibiotics for SIBO in the context of CP; however, recent data show a possible role of probiotics as an adjunctive therapy to antibiotics in SIBO treatment [<xref rid="B83-nutrients-17-02720" ref-type="bibr">83</xref>]. A relatively recent prospective, randomised, controlled, double-blind clinical trial on 60 patients with CP reported that a mix of probiotic and prebiotic supplements (<italic toggle="yes">Lactobacillus casei</italic>, <italic toggle="yes">Lactobacillus rhamnosus</italic>, <italic toggle="yes">Lactobacillus acidophilus</italic>, <italic toggle="yes">Bifidobacterium bifidum</italic> and fructooligosaccharides) significantly improved laboratory measures in CP patients and decreased the number of patients with diarrhoea [<xref rid="B84-nutrients-17-02720" ref-type="bibr">84</xref>]. Moreover, another prospective, single-blind, randomised, controlled trial including 75 patients with CP undergoing Frey&#8217;s procedure, a type of partial pancreatectomy, showed that perioperative probiotic and prebiotic therapy (<italic toggle="yes">Streptococcus faecalis</italic>, <italic toggle="yes">Clostridium butyricum</italic>, <italic toggle="yes">Bacillus mesentericus</italic>, <italic toggle="yes">Lactobacillus sporogenes</italic> and fructooligosaccharides) markedly reduced postoperative infections and hospital stay [<xref rid="B98-nutrients-17-02720" ref-type="bibr">98</xref>]. No data is currently available on different ways to modulate microbiota, such as other types of probiotics, postbiotics, functional foods or faecal microbiota transplantation [<xref rid="B99-nutrients-17-02720" ref-type="bibr">99</xref>].</p></sec><sec id="sec6dot3-nutrients-17-02720"><title>6.3. Genetic Predisposition in Chronic Pancreatitis</title><p>Hereditary chronic pancreatitis (HCP) is a very rare form of early-onset chronic pancreatitis [<xref rid="B100-nutrients-17-02720" ref-type="bibr">100</xref>]. Eighty percent of family members with HCP have recurrent acute pancreatitis leading to chronic pancreatitis due to mutations in the cationic trypsinogen (PRSS1) gene. In addition to HCP, a number of genetic variations, in order of decreasing risk effect in the PRSS1, CPA1, SPINK1, CTRC, CEL and CFTR genes, have been found to raise the risk of developing chronic pancreatitis, particularly when other risk factors are present [<xref rid="B101-nutrients-17-02720" ref-type="bibr">101</xref>]. Heterozygous or homozygous mutations in these genes accelerate disease onset and severity, and identifying them allows risk stratification and tailored interventions [<xref rid="B101-nutrients-17-02720" ref-type="bibr">101</xref>]. According to current guidelines, individuals under 20 years of age and those with a family history of two or more first- or second-degree relatives with CP should obtain genetic testing [<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>]. Outside of research, genetic testing for other genes is not advised, and only a sweat test should be carried out to rule out cystic fibrosis in adults with idiopathic CP who do not exhibit any additional clinical symptoms of the disease [<xref rid="B28-nutrients-17-02720" ref-type="bibr">28</xref>]. Out of the abovementioned genes, the only targetable one is CFTR (cystic fibrosis transmembrane conductance regulator), which impairs ductal ion transport, yielding a higher CP risk. Early use (between 12 and 24 months) of CFTR modulators in cystic fibrosis may allow the recovery of pancreatic function, which on one hand may reduce the detrimental effects of severe EPI, but on the other may increase the number of CP recurrences due to the existence of remaining acinar cells which can cause new attacks [<xref rid="B102-nutrients-17-02720" ref-type="bibr">102</xref>,<xref rid="B103-nutrients-17-02720" ref-type="bibr">103</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec7-nutrients-17-02720"><title>7. Conclusions and Future Perspectives</title><p>CP imposes a persistent catabolic state that, combined with both exocrine and endocrine insufficiency, contributes to complex malnutrition, progressive sarcopenia, metabolic bone disease, and micronutrient deficiencies (<xref rid="nutrients-17-02720-t004" ref-type="table">Table 4</xref>). Early identification through a combined phenotypic and etiologic evaluation, followed by timely initiation of pancreatic enzyme replacement therapy, is essential to restore effective intraluminal digestion and to avert deficiencies in fat-soluble vitamins.</p><p>High-protein feeding (&#8805;1.2 g kg<sup>&#8722;1</sup> day<sup>&#8722;1</sup>), judicious fat provision assisted by adequate lipase dosing, and systematic repletion of vitamins A, D, E, K, calcium and trace elements mitigate muscle wasting, bone loss and immune compromise. Multidisciplinary programmes integrating dietetics, endocrinology, analgesia and psychosocial support demonstrably reduce hospitalisations and improve quality of life.</p><p>Looking into the future, precision-nutrition algorithms that combine faecal elastase-1 stratification, metabolomic profiling and imaging-based body composition may allow enzyme and nutrient prescriptions to be titrated in real time. Randomised trials are needed to define the ideal lipid fraction, clarify the role of probiotics and evaluate the long-term skeletal impact of early CFTR modulation.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualisation, A.B. and L.C.; methodology D.S. and G.D. (Giuseppe Dell&#8217;Anna); validation, A.B., L.C. and D.S.; formal analysis, A.L.; investigation, D.S. and F.V.M.; resources, G.D. (Gianfranco Donatelli); data curation, G.M.; writing&#8212;original draft preparation, A.B.; writing&#8212;review and editing, A.L., P.C. and L.C.; visualisation, D.S. and G.D. (Gianfranco Donatelli); supervision, G.B. and L.F.; project administration, G.B. and L.H.E. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADEK</td><td align="left" valign="middle" rowspan="1" colspan="1">Fat-soluble vitamins A, D, E and K</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BIA</td><td align="left" valign="middle" rowspan="1" colspan="1">Bioelectrical impedance analysis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMD</td><td align="left" valign="middle" rowspan="1" colspan="1">Bone mineral density</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI</td><td align="left" valign="middle" rowspan="1" colspan="1">Body mass index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CCK</td><td align="left" valign="middle" rowspan="1" colspan="1">Cholecystokinin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CEL</td><td align="left" valign="middle" rowspan="1" colspan="1">Carboxyl-ester lipase gene</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CFA</td><td align="left" valign="middle" rowspan="1" colspan="1">Coefficient of fat absorption</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CFTR</td><td align="left" valign="middle" rowspan="1" colspan="1">Cystic fibrosis transmembrane conductance regulator</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPA1</td><td align="left" valign="middle" rowspan="1" colspan="1">Carboxypeptidase A1 gene</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CP</td><td align="left" valign="middle" rowspan="1" colspan="1">Chronic pancreatitis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CRP</td><td align="left" valign="middle" rowspan="1" colspan="1">C-reactive protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CTRC</td><td align="left" valign="middle" rowspan="1" colspan="1">Chymotrypsin C gene</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DXA</td><td align="left" valign="middle" rowspan="1" colspan="1">Dual-energy X-ray absorptiometry</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EN</td><td align="left" valign="middle" rowspan="1" colspan="1">Enteral nutrition</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EPI</td><td align="left" valign="middle" rowspan="1" colspan="1">Exocrine pancreatic insufficiency</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FE-1</td><td align="left" valign="middle" rowspan="1" colspan="1">Faecal elastase-1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GLIM</td><td align="left" valign="middle" rowspan="1" colspan="1">Global Leadership Initiative on Malnutrition</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCP</td><td align="left" valign="middle" rowspan="1" colspan="1">Hereditary chronic pancreatitis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IL-6</td><td align="left" valign="middle" rowspan="1" colspan="1">Interleukin-6</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LCFA</td><td align="left" valign="middle" rowspan="1" colspan="1">Long-chain fatty acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LD</td><td align="left" valign="middle" rowspan="1" colspan="1">Linear dichroism</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MCT</td><td align="left" valign="middle" rowspan="1" colspan="1">Medium-chain triglyceride</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MUST</td><td align="left" valign="middle" rowspan="1" colspan="1">Malnutrition Universal Screening Tool</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ONS</td><td align="left" valign="middle" rowspan="1" colspan="1">Oral nutritional supplementation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PERT</td><td align="left" valign="middle" rowspan="1" colspan="1">Pancreatic enzyme replacement therapy</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PINP</td><td align="left" valign="middle" rowspan="1" colspan="1">Procollagen type I N-terminal propeptide</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PN</td><td align="left" valign="middle" rowspan="1" colspan="1">Parenteral nutrition</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PRSS1</td><td align="left" valign="middle" rowspan="1" colspan="1">Protease serine 1 gene (cationic trypsinogen)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RXR</td><td align="left" valign="middle" rowspan="1" colspan="1">Retinoid X receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SIBO</td><td align="left" valign="middle" rowspan="1" colspan="1">Small-intestinal bacterial overgrowth</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SPINK1</td><td align="left" valign="middle" rowspan="1" colspan="1">Serine peptidase inhibitor, Kazal type 1 gene</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TLA</td><td align="left" valign="middle" rowspan="1" colspan="1">Three-letter acronym</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TNF-&#945;</td><td align="left" valign="middle" rowspan="1" colspan="1">Tumour necrosis factor-alpha</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VDR</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin D receptor</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VDREs</td><td align="left" valign="middle" rowspan="1" colspan="1">Vitamin D response elements</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-nutrients-17-02720"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arvanitakis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ockenga</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bezmarevic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gianotti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Krznari&#263;</surname><given-names>&#381;.</given-names></name><name name-style="western"><surname>Lobo</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>L&#246;ser</surname><given-names>C.</given-names></name><name name-style="western"><surname>Madl</surname><given-names>C.</given-names></name><name name-style="western"><surname>Meier</surname><given-names>R.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>M.</given-names></name><etal/></person-group><article-title>ESPEN practical guideline on clinical nutrition in acute and chronic pancreatitis</article-title><source>Clin. Nutr.</source><year>2024</year><volume>43</volume><fpage>395</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2023.12.019</pub-id><pub-id pub-id-type="pmid">38169174</pub-id></element-citation></ref><ref id="B2-nutrients-17-02720"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cederholm</surname><given-names>T.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Correia</surname><given-names>M.I.T.D.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Fukushima</surname><given-names>R.</given-names></name><name name-style="western"><surname>Higashiguchi</surname><given-names>T.</given-names></name><name name-style="western"><surname>Baptista</surname><given-names>G.</given-names></name><name name-style="western"><surname>Barazzoni</surname><given-names>R.</given-names></name><name name-style="western"><surname>Blaauw</surname><given-names>R.</given-names></name><name name-style="western"><surname>Coats</surname><given-names>A.J.</given-names></name><etal/></person-group><article-title>GLIM criteria for the diagnosis of malnutrition&#8212;A consensus report from the global clinical nutrition community</article-title><source>Clin. Nutr.</source><year>2019</year><volume>38</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2018.08.002</pub-id><pub-id pub-id-type="pmid">30181091</pub-id></element-citation></ref><ref id="B3-nutrients-17-02720"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petermann-Rocha</surname><given-names>F.</given-names></name><name name-style="western"><surname>Balntzi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Lara</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>F.K.</given-names></name><name name-style="western"><surname>Pell</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Celis-Morales</surname><given-names>C.</given-names></name></person-group><article-title>Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis</article-title><source>J. Cachexia-Sarcopenia Muscle</source><year>2022</year><volume>13</volume><fpage>86</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1002/jcsm.12783</pub-id><pub-id pub-id-type="pmid">34816624</pub-id><pub-id pub-id-type="pmcid">PMC8818604</pub-id></element-citation></ref><ref id="B4-nutrients-17-02720"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khurmatullina</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Andreev</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Maev</surname><given-names>I.V.</given-names></name><name name-style="western"><surname>Kucheryavyy</surname><given-names>Y.A.</given-names></name><name name-style="western"><surname>Beliy</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Dzhafarova</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Cherenkova</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Sokolov</surname><given-names>F.S.</given-names></name></person-group><article-title>Prevalence and Risk of Sarcopenia in Patients with Chronic Pancreatitis: Systematic Review and Meta-Analysis</article-title><source>Nutrients</source><year>2025</year><volume>17</volume><elocation-id>870</elocation-id><pub-id pub-id-type="doi">10.3390/nu17050870</pub-id><pub-id pub-id-type="pmid">40077740</pub-id><pub-id pub-id-type="pmcid">PMC11902046</pub-id></element-citation></ref><ref id="B5-nutrients-17-02720"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>D.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>P.K.</given-names></name></person-group><article-title>Diagnosis and Management of Chronic Pancreatitis, A Review</article-title><source>JAMA J. Am. Med. Assoc.</source><year>2019</year><volume>322</volume><fpage>2422</fpage><lpage>2434</lpage><pub-id pub-id-type="doi">10.1001/jama.2019.19411</pub-id><pub-id pub-id-type="pmid">31860051</pub-id></element-citation></ref><ref id="B6-nutrients-17-02720"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lenti</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Tacheci</surname><given-names>I.</given-names></name><name name-style="western"><surname>Burgos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>S.</given-names></name><name name-style="western"><surname>Foteini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Derovs</surname><given-names>A.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Broekaert</surname><given-names>I.</given-names></name><name name-style="western"><surname>Arvanitakis</surname><given-names>M.</given-names></name><etal/></person-group><article-title>European Consensus on Malabsorption&#8212;UEG &amp; SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption</article-title><source>United Eur. Gastroenterol. J.</source><year>2025</year><volume>13</volume><fpage>599</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1002/ueg2.70012</pub-id><pub-id pub-id-type="pmcid">PMC12090837</pub-id><pub-id pub-id-type="pmid">40129317</pub-id></element-citation></ref><ref id="B7-nutrients-17-02720"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lenti</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Hammer</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Tacheci</surname><given-names>I.</given-names></name><name name-style="western"><surname>Burgos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>S.</given-names></name><name name-style="western"><surname>Foteini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Derovs</surname><given-names>A.</given-names></name><name name-style="western"><surname>Keller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Broekaert</surname><given-names>I.</given-names></name><name name-style="western"><surname>Arvanitakis</surname><given-names>M.</given-names></name><etal/></person-group><article-title>European Consensus on Malabsorption&#8212;UEG &amp; SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective</article-title><source>United Eur. Gastroenterol. J.</source><year>2025</year><volume>13</volume><fpage>773</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1002/ueg2.70011</pub-id><pub-id pub-id-type="pmcid">PMC12188380</pub-id><pub-id pub-id-type="pmid">40088199</pub-id></element-citation></ref><ref id="B8-nutrients-17-02720"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardner</surname><given-names>T.B.</given-names></name><name name-style="western"><surname>Adler</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Forsmark</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Sauer</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Whitcomb</surname><given-names>D.C.</given-names></name></person-group><article-title>ACG Clinical Guideline: Chronic Pancreatitis</article-title><source>Am. J. Gastroenterol.</source><year>2020</year><volume>115</volume><fpage>322</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.14309/ajg.0000000000000535</pub-id><pub-id pub-id-type="pmid">32022720</pub-id></element-citation></ref><ref id="B9-nutrients-17-02720"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dominguez-Mu&#241;oz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Vujasinovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>de la Iglesia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cahen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gubergrits</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hegyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hungin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ockenga</surname><given-names>J.</given-names></name><name name-style="western"><surname>Paiella</surname><given-names>S.</given-names></name><etal/></person-group><article-title>European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations</article-title><source>United Eur. Gastroenterol. J.</source><year>2024</year><volume>13</volume><fpage>125</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/ueg2.12674</pub-id><pub-id pub-id-type="pmcid">PMC11866322</pub-id><pub-id pub-id-type="pmid">39639485</pub-id></element-citation></ref><ref id="B10-nutrients-17-02720"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peery</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Crockett</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Egberg</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Lund</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Moon</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Pate</surname><given-names>V.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>E.L.</given-names></name><etal/></person-group><article-title>Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021</article-title><source>Gastroenterology</source><year>2022</year><volume>162</volume><fpage>621</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2021.10.017</pub-id><pub-id pub-id-type="pmid">34678215</pub-id><pub-id pub-id-type="pmcid">PMC10756322</pub-id></element-citation></ref><ref id="B11-nutrients-17-02720"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lv</surname><given-names>Y.-W.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>L.-H.</given-names></name></person-group><article-title>Management of chronic pancreatitis: Recent advances and future prospects</article-title><source>Ther. Adv. Gastroenterol.</source><year>2024</year><volume>17</volume><fpage>17562848241234480</fpage><pub-id pub-id-type="doi">10.1177/17562848241234480</pub-id><pub-id pub-id-type="pmcid">PMC10894541</pub-id><pub-id pub-id-type="pmid">38406795</pub-id></element-citation></ref><ref id="B12-nutrients-17-02720"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DE Thierens</surname><given-names>N.</given-names></name><name name-style="western"><surname>Verdonk</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>L&#246;hr</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>van Santvoort</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Bouwense</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>E van Hooft</surname><given-names>J.</given-names></name></person-group><article-title>Chronic pancreatitis</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>2605</fpage><lpage>2618</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)02187-1</pub-id><pub-id pub-id-type="pmid">39647500</pub-id></element-citation></ref><ref id="B13-nutrients-17-02720"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiMagno</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Go</surname><given-names>V.L.W.</given-names></name><name name-style="western"><surname>Summerskill</surname><given-names>W.H.J.</given-names></name></person-group><article-title>Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic Insufficiency</article-title><source>N. Engl. J. Med.</source><year>1973</year><volume>288</volume><fpage>813</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1056/NEJM197304192881603</pub-id><pub-id pub-id-type="pmid">4693931</pub-id></element-citation></ref><ref id="B14-nutrients-17-02720"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madro</surname><given-names>A.</given-names></name></person-group><article-title>Malnutrition in Chronic Pancreatitis: Causes, Assessment Methods, and Therapeutic Management</article-title><source>Can. J. Gastroenterol. Hepatol.</source><year>2020</year><volume>2020</volume><fpage>8875487</fpage><pub-id pub-id-type="doi">10.1155/2020/8875487</pub-id><pub-id pub-id-type="pmid">32832490</pub-id><pub-id pub-id-type="pmcid">PMC7429756</pub-id></element-citation></ref><ref id="B15-nutrients-17-02720"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-J.</given-names></name><name name-style="western"><surname>Han</surname><given-names>Y.-P.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Z.-Q.</given-names></name><name name-style="western"><surname>Deng</surname><given-names>L.-H.</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Q.</given-names></name></person-group><article-title>Vitamin D and Pancreatitis: A Narrative Review of Current Evidence</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><elocation-id>2113</elocation-id><pub-id pub-id-type="doi">10.3390/nu14102113</pub-id><pub-id pub-id-type="pmid">35631254</pub-id><pub-id pub-id-type="pmcid">PMC9143310</pub-id></element-citation></ref><ref id="B16-nutrients-17-02720"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Bellin</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Andersen</surname><given-names>D.K.</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>D.</given-names></name><name name-style="western"><surname>Cruz-Monserrate</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Forsmark</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>O Goodarzi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Habtezion</surname><given-names>A.</given-names></name><name name-style="western"><surname>Korc</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kudva</surname><given-names>Y.C.</given-names></name><etal/></person-group><article-title>Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer</article-title><source>Lancet Gastroenterol. Hepatol.</source><year>2016</year><volume>1</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/S2468-1253(16)30106-6</pub-id><pub-id pub-id-type="pmid">28404095</pub-id><pub-id pub-id-type="pmcid">PMC5495015</pub-id></element-citation></ref><ref id="B17-nutrients-17-02720"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viggers</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>M.H.</given-names></name><name name-style="western"><surname>Laursen</surname><given-names>H.V.B.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Vestergaard</surname><given-names>P.</given-names></name><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name></person-group><article-title>Glucose-Lowering Therapy in Patients With Postpancreatitis Diabetes Mellitus: A Nationwide Population-Based Cohort Study</article-title><source>Diabetes Care</source><year>2021</year><volume>44</volume><fpage>2045</fpage><lpage>2052</lpage><pub-id pub-id-type="doi">10.2337/dc21-0333</pub-id><pub-id pub-id-type="pmid">34362812</pub-id></element-citation></ref><ref id="B18-nutrients-17-02720"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campagnola</surname><given-names>P.</given-names></name><name name-style="western"><surname>de Pretis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zorzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Caldart</surname><given-names>F.</given-names></name><name name-style="western"><surname>Frulloni</surname><given-names>L.</given-names></name></person-group><article-title>Chronic pancreatitis and nutritional support</article-title><source>Best Pract. Res. Clin. Gastroenterol.</source><year>2023</year><volume>62&#8211;63</volume><fpage>101823</fpage><pub-id pub-id-type="doi">10.1016/j.bpg.2023.101823</pub-id><pub-id pub-id-type="pmid">37094906</pub-id></element-citation></ref><ref id="B19-nutrients-17-02720"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vu</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Vecht</surname><given-names>J.</given-names></name><name name-style="western"><surname>Eddes</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Biemond</surname><given-names>I.</given-names></name><name name-style="western"><surname>Lamers</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Masclee</surname><given-names>A.A.</given-names></name></person-group><article-title>Antroduodenal motility in chronic pancreatitis: Are abnormalities related to exocrine insufficiency?</article-title><source>Am. J. Physiol. Gastrointest. Liver Physiol.</source><year>2000</year><volume>278</volume><fpage>458</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.2000.278.3.G458</pub-id><pub-id pub-id-type="pmid">10712266</pub-id></element-citation></ref><ref id="B20-nutrients-17-02720"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Wamsteker</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>R.</given-names></name><name name-style="western"><surname>DiMagno</surname><given-names>M.J.</given-names></name></person-group><article-title>Small Intestinal Bacterial Overgrowth is Common in Chronic Pancreatitis (CP) and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use</article-title><source>Am. J. Gastroenterol.</source><year>2019</year><volume>114</volume><fpage>1163</fpage><lpage>1171</lpage><pub-id pub-id-type="doi">10.14309/ajg.0000000000000200</pub-id><pub-id pub-id-type="pmid">31008737</pub-id><pub-id pub-id-type="pmcid">PMC6610753</pub-id></element-citation></ref><ref id="B21-nutrients-17-02720"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akshintala</surname><given-names>V.S.</given-names></name><name name-style="western"><surname>Talukdar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>Goggins</surname><given-names>M.</given-names></name></person-group><article-title>The Gut Microbiome in Pancreatic Disease</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2019</year><volume>17</volume><fpage>290</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2018.08.045</pub-id><pub-id pub-id-type="pmid">30144522</pub-id><pub-id pub-id-type="pmcid">PMC6314887</pub-id></element-citation></ref><ref id="B22-nutrients-17-02720"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mare&#537;</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>S&#259;s&#259;ran</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>M&#259;rginean</surname><given-names>C.O.</given-names></name></person-group><article-title>Small Intestinal Bacterial Overgrowth and Childhood Malnutrition: A Comprehensive Review of Available Evidence</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><elocation-id>4319</elocation-id><pub-id pub-id-type="doi">10.3390/nu16244319</pub-id><pub-id pub-id-type="pmid">39770940</pub-id><pub-id pub-id-type="pmcid">PMC11679674</pub-id></element-citation></ref><ref id="B23-nutrients-17-02720"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#246;hr</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Vujasinovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rosendahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stone</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Beuers</surname><given-names>U.</given-names></name></person-group><article-title>IgG4-related diseases of the digestive tract</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2022</year><volume>19</volume><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/s41575-021-00529-y</pub-id><pub-id pub-id-type="pmid">34750548</pub-id></element-citation></ref><ref id="B24-nutrients-17-02720"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>Z.S.</given-names></name><name name-style="western"><surname>Katz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hernandez-Barco</surname><given-names>Y.G.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>M.C.</given-names></name></person-group><article-title>Current and future advances in practice: IgG4-related disease</article-title><source>Rheumatol. Adv. Pract.</source><year>2024</year><volume>8</volume><fpage>rkae020</fpage><pub-id pub-id-type="doi">10.1093/rap/rkae020</pub-id><pub-id pub-id-type="pmid">38601138</pub-id><pub-id pub-id-type="pmcid">PMC11003820</pub-id></element-citation></ref><ref id="B25-nutrients-17-02720"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vujasinovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nikolic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Achour</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>L&#246;hr</surname><given-names>J.M.</given-names></name></person-group><article-title>Autoimmune pancreatitis and micronutrients</article-title><source>Dig. Liver Dis.</source><year>2023</year><volume>55</volume><fpage>1375</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1016/j.dld.2023.04.009</pub-id><pub-id pub-id-type="pmid">37121818</pub-id></element-citation></ref><ref id="B26-nutrients-17-02720"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vujasinovic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hedstr&#246;m</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maisonneuve</surname><given-names>P.</given-names></name><name name-style="western"><surname>Valente</surname><given-names>R.</given-names></name><name name-style="western"><surname>von Horn</surname><given-names>H.</given-names></name><name name-style="western"><surname>L&#246;hr</surname><given-names>J.-M.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.L.</given-names></name></person-group><article-title>Zinc deficiency in patients with chronic pancreatitis</article-title><source>World J. Gastroenterol.</source><year>2019</year><volume>25</volume><fpage>600</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.3748/wjg.v25.i5.600</pub-id><pub-id pub-id-type="pmid">30774274</pub-id><pub-id pub-id-type="pmcid">PMC6371007</pub-id></element-citation></ref><ref id="B27-nutrients-17-02720"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>J&#248;ker-Jensen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mathiasen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>K&#248;hler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name></person-group><article-title>Micronutrient deficits in patients with chronic pancreatitis: Prevalence, risk factors and pitfalls</article-title><source>Eur. J. Gastroenterol. Hepatol.</source><year>2020</year><volume>32</volume><fpage>1328</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1097/MEG.0000000000001866</pub-id><pub-id pub-id-type="pmid">32732813</pub-id></element-citation></ref><ref id="B28-nutrients-17-02720"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#246;hr</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Dominguez-Munoz</surname><given-names>E.</given-names></name><name name-style="western"><surname>Rosendahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Besselink</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mayerle</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.</given-names></name><name name-style="western"><surname>Akisik</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kartalis</surname><given-names>N.</given-names></name><name name-style="western"><surname>Iglesias-Garcia</surname><given-names>J.</given-names></name><etal/></person-group><article-title>United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)</article-title><source>United Eur. Gastroenterol. J.</source><year>2017</year><volume>5</volume><fpage>153</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1177/2050640616684695</pub-id><pub-id pub-id-type="pmcid">PMC5349368</pub-id><pub-id pub-id-type="pmid">28344786</pub-id></element-citation></ref><ref id="B29-nutrients-17-02720"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Iglesia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Avci</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kiriukova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Panic</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bozhychko</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sandru</surname><given-names>V.</given-names></name><name name-style="western"><surname>de Madaria</surname><given-names>E.</given-names></name><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name></person-group><article-title>Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis</article-title><source>United Eur. Gastroenterol. J.</source><year>2020</year><volume>8</volume><fpage>1115</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1177/2050640620938987</pub-id><pub-id pub-id-type="pmcid">PMC7724551</pub-id><pub-id pub-id-type="pmid">32631175</pub-id></element-citation></ref><ref id="B30-nutrients-17-02720"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Iglesia-Garcia</surname><given-names>D.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Szatmary</surname><given-names>P.</given-names></name><name name-style="western"><surname>Baston-Rey</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-L&#243;pez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Prada-Ramallal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>R.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>Q.M.</given-names></name><name name-style="western"><surname>Dominguez-Munoz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: Systematic review and meta-analysis</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>1354</fpage><lpage>1355</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2016-312529</pub-id><pub-id pub-id-type="pmid">27941156</pub-id><pub-id pub-id-type="pmcid">PMC5530474</pub-id></element-citation></ref><ref id="B31-nutrients-17-02720"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tacelli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vanella</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pisani</surname><given-names>R.P.d.L.</given-names></name><name name-style="western"><surname>Dell&#8217;aNna</surname><given-names>G.</given-names></name><name name-style="western"><surname>Abati</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mele</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lauri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Panaitescu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nunziata</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Managing complications of chronic pancreatitis: A guide for the gastroenterologist</article-title><source>Expert Rev. Gastroenterol. Hepatol.</source><year>2023</year><volume>17</volume><fpage>1267</fpage><lpage>1283</lpage><pub-id pub-id-type="doi">10.1080/17474124.2023.2295498</pub-id><pub-id pub-id-type="pmid">38093702</pub-id></element-citation></ref><ref id="B32-nutrients-17-02720"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Poulsen</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Fr&#248;kj&#230;r</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Laukkarinen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Parhiala</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rix</surname><given-names>I.</given-names></name><name name-style="western"><surname>Novovic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lindkvist</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bexander</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The Scandinavian baltic pancreatic club (SBPC) database: Design, rationale and characterisation of the study cohort</article-title><source>Scand. J. Gastroenterol.</source><year>2017</year><volume>52</volume><fpage>909</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1080/00365521.2017.1322138</pub-id><pub-id pub-id-type="pmid">28471312</pub-id></element-citation></ref><ref id="B33-nutrients-17-02720"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kempeneers</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>U.A.</given-names></name><name name-style="western"><surname>Issa</surname><given-names>Y.</given-names></name><name name-style="western"><surname>van Goor</surname><given-names>H.</given-names></name><name name-style="western"><surname>Drenth</surname><given-names>J.P.H.</given-names></name><name name-style="western"><surname>van Dullemen</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>van Hooft</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Poen</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>van Veldhuisen</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Besselink</surname><given-names>M.G.</given-names></name><etal/></person-group><article-title>Natural Course and Treatment of Pancreatic Exocrine Insufficiency in a Nationwide Cohort of Chronic Pancreatitis</article-title><source>Pancreas</source><year>2020</year><volume>49</volume><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000001473</pub-id><pub-id pub-id-type="pmid">32011528</pub-id></element-citation></ref><ref id="B34-nutrients-17-02720"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Machicado</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Chari</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Timmons</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>D.</given-names></name></person-group><article-title>A population-based evaluation of the natural history of chronic pancreatitis</article-title><source>Pancreatology</source><year>2018</year><volume>18</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2017.11.012</pub-id><pub-id pub-id-type="pmid">29221631</pub-id><pub-id pub-id-type="pmcid">PMC5794616</pub-id></element-citation></ref><ref id="B35-nutrients-17-02720"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Layer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kalthoff</surname><given-names>L.</given-names></name><name name-style="western"><surname>Clain</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Bakken</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>DiMagno</surname><given-names>E.P.</given-names></name></person-group><article-title>The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis</article-title><source>Gastroenterology</source><year>1994</year><volume>107</volume><fpage>1481</fpage><lpage>1487</lpage><pub-id pub-id-type="doi">10.1016/0016-5085(94)90553-3</pub-id><pub-id pub-id-type="pmid">7926511</pub-id></element-citation></ref><ref id="B36-nutrients-17-02720"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dom&#237;nguez-Mu&#241;oz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>&#193;lvarez-Castro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lari&#241;o-Noia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nieto</surname><given-names>L.</given-names></name><name name-style="western"><surname>Iglesias-Garc&#237;a</surname><given-names>J.</given-names></name></person-group><article-title>Endoscopic Ultrasonography of the Pancreas as an Indirect Method to Predict Pancreatic Exocrine Insufficiency in Patients with Chronic Pancreatitis</article-title><source>Pancreas</source><year>2012</year><volume>41</volume><fpage>724</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1097/MPA.0b013e31823b5978</pub-id><pub-id pub-id-type="pmid">22228053</pub-id></element-citation></ref><ref id="B37-nutrients-17-02720"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dom&#237;nguez-Mu&#241;oz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Hardt</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>L&#246;hr</surname><given-names>M.J.</given-names></name></person-group><article-title>Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test</article-title><source>Dig. Dis. Sci.</source><year>2017</year><volume>62</volume><fpage>1119</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1007/s10620-017-4524-z</pub-id><pub-id pub-id-type="pmid">28315028</pub-id></element-citation></ref><ref id="B38-nutrients-17-02720"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanga</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Tansel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sidiq</surname><given-names>S.</given-names></name><name name-style="western"><surname>El-Serag</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Othman</surname><given-names>M.O.</given-names></name></person-group><article-title>Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2018</year><volume>16</volume><fpage>1220</fpage><lpage>1228.e4</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2018.01.027</pub-id><pub-id pub-id-type="pmid">29374614</pub-id><pub-id pub-id-type="pmcid">PMC6402774</pub-id></element-citation></ref><ref id="B39-nutrients-17-02720"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kroon</surname><given-names>V.</given-names></name><name name-style="western"><surname>Daamen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>D.</given-names></name><name name-style="western"><surname>de Vreugd</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Brada</surname><given-names>L.</given-names></name><name name-style="western"><surname>Busch</surname><given-names>O.</given-names></name><name name-style="western"><surname>Derksen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gerritsen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rombouts</surname><given-names>S.</given-names></name><name name-style="western"><surname>Smits</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Pancreatic exocrine insufficiency following pancreatoduodenectomy: A prospective bi-center study</article-title><source>Pancreatology</source><year>2022</year><volume>22</volume><fpage>1020</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2022.08.002</pub-id><pub-id pub-id-type="pmid">35961936</pub-id></element-citation></ref><ref id="B40-nutrients-17-02720"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Molenaar</surname><given-names>I.Q.</given-names></name><name name-style="western"><surname>Besselink</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>van Eijck</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Rinkes</surname><given-names>I.H.B.</given-names></name><name name-style="western"><surname>van Santvoort</surname><given-names>H.C.</given-names></name></person-group><article-title>Pancreatic Exocrine Insufficiency in Patients With Pancreatic or Periampullary Cancer</article-title><source>Pancreas</source><year>2016</year><volume>45</volume><fpage>325</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000000473</pub-id><pub-id pub-id-type="pmid">26495777</pub-id></element-citation></ref><ref id="B41-nutrients-17-02720"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dell&#8217;anna</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fanizzi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zilli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Furfaro</surname><given-names>F.</given-names></name><name name-style="western"><surname>Solitano</surname><given-names>V.</given-names></name><name name-style="western"><surname>Parigi</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Ciliberto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fanizza</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mandarino</surname><given-names>F.V.</given-names></name><name name-style="western"><surname>Fuccio</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies</article-title><source>Nutrients</source><year>2025</year><volume>17</volume><elocation-id>2167</elocation-id><pub-id pub-id-type="doi">10.3390/nu17132167</pub-id><pub-id pub-id-type="pmid">40647273</pub-id><pub-id pub-id-type="pmcid">PMC12252289</pub-id></element-citation></ref><ref id="B42-nutrients-17-02720"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindkvist</surname><given-names>B.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Dom&#237;nguez-Mu&#241;oz</surname><given-names>J.E.</given-names></name></person-group><article-title>Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use</article-title><source>Pancreatology</source><year>2015</year><volume>15</volume><fpage>589</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2015.07.001</pub-id><pub-id pub-id-type="pmid">26243045</pub-id></element-citation></ref><ref id="B43-nutrients-17-02720"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>M.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Hart</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pencavel</surname><given-names>T.</given-names></name></person-group><article-title>Long-term effects of clinical interventions on nutritional status in patients with chronic pancreatitis&#8212;A systematic review</article-title><source>Clin. Nutr. ESPEN</source><year>2022</year><volume>48</volume><fpage>178</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.clnesp.2021.12.032</pub-id><pub-id pub-id-type="pmid">35331489</pub-id></element-citation></ref><ref id="B44-nutrients-17-02720"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gopi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Qamar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yegurla</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rana</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gunjan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saraya</surname><given-names>A.</given-names></name></person-group><article-title>Malnutrition by GLIM criteria in chronic pancreatitis: Prevalence, predictors, and its impact on quality of life</article-title><source>Pancreatology</source><year>2022</year><volume>22</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2022.02.004</pub-id><pub-id pub-id-type="pmid">35210181</pub-id></element-citation></ref><ref id="B45-nutrients-17-02720"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiese</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>G&#228;rtner</surname><given-names>S.</given-names></name><name name-style="western"><surname>von Essen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Doller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Frost</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>Q.T.</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>F.U.</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>F.</given-names></name><name name-style="western"><surname>Valentini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Garbe</surname><given-names>L.-A.</given-names></name><etal/></person-group><article-title>Malnutrition Is Highly Prevalent in Patients with Chronic Pancreatitis and Characterized by Loss of Skeletal Muscle Mass but Absence of Impaired Physical Function</article-title><source>Front. Nutr.</source><year>2022</year><volume>9</volume><elocation-id>889489</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2022.889489</pub-id><pub-id pub-id-type="pmid">35719155</pub-id><pub-id pub-id-type="pmcid">PMC9202591</pub-id></element-citation></ref><ref id="B46-nutrients-17-02720"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bundred</surname><given-names>J.</given-names></name><name name-style="western"><surname>Thakkar</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Pandanaboyana</surname><given-names>S.</given-names></name></person-group><article-title>Systematic review of sarcopenia in chronic pancreatitis: Prevalence, impact on surgical outcomes, and survival</article-title><source>Expert Rev. Gastroenterol. Hepatol.</source><year>2022</year><volume>16</volume><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1080/17474124.2022.2091544</pub-id><pub-id pub-id-type="pmid">35712996</pub-id></element-citation></ref><ref id="B47-nutrients-17-02720"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cruz-Jentoft</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Bahat</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bauer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Boirie</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bruy&#232;re</surname><given-names>O.</given-names></name><name name-style="western"><surname>Cederholm</surname><given-names>T.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>C.</given-names></name><name name-style="western"><surname>Landi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rolland</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Sayer</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>Sarcopenia: Revised European consensus on definition and diagnosis</article-title><source>Age Ageing</source><year>2019</year><volume>48</volume><fpage>16</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/ageing/afy169</pub-id><pub-id pub-id-type="pmid">30312372</pub-id><pub-id pub-id-type="pmcid">PMC6322506</pub-id></element-citation></ref><ref id="B48-nutrients-17-02720"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>B&#252;y&#252;kuslu</surname><given-names>A.</given-names></name><name name-style="western"><surname>K&#248;hler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name></person-group><article-title>Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis</article-title><source>Pancreatology</source><year>2019</year><volume>19</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2019.01.006</pub-id><pub-id pub-id-type="pmid">30665702</pub-id></element-citation></ref><ref id="B49-nutrients-17-02720"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramai</surname><given-names>D.</given-names></name><name name-style="western"><surname>Facciorusso</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maida</surname><given-names>M.</given-names></name><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chandan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Spadaccini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Repici</surname><given-names>A.</given-names></name><name name-style="western"><surname>Duggan</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Prevalence of Osteopathy in Chronic Pancreatitis: A Systematic Review and Meta-Analysis</article-title><source>Clin. Transl. Gastroenterol.</source><year>2023</year><volume>14</volume><fpage>e00623</fpage><pub-id pub-id-type="doi">10.14309/ctg.0000000000000623</pub-id><pub-id pub-id-type="pmid">37477620</pub-id><pub-id pub-id-type="pmcid">PMC10461948</pub-id></element-citation></ref><ref id="B50-nutrients-17-02720"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoogenboom</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lekkerkerker</surname><given-names>S.</given-names></name><name name-style="western"><surname>Fockens</surname><given-names>P.</given-names></name><name name-style="western"><surname>Boermeester</surname><given-names>M.</given-names></name><name name-style="western"><surname>van Hooft</surname><given-names>J.</given-names></name></person-group><article-title>Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis</article-title><source>Pancreatology</source><year>2016</year><volume>16</volume><fpage>800</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2016.07.010</pub-id><pub-id pub-id-type="pmid">27453461</pub-id></element-citation></ref><ref id="B51-nutrients-17-02720"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>O&#8217;SUllivan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feehan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ridgway</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Conlon</surname><given-names>K.C.</given-names></name></person-group><article-title>The Prevalence of Malnutrition and Fat-Soluble Vitamin Deficiencies in Chronic Pancreatitis</article-title><source>Nutr. Clin. Pract.</source><year>2014</year><volume>29</volume><fpage>348</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1177/0884533614528361</pub-id><pub-id pub-id-type="pmid">24727205</pub-id></element-citation></ref><ref id="B52-nutrients-17-02720"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Purcell</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kilbane</surname><given-names>M.</given-names></name><name name-style="western"><surname>O&#8217;KEane</surname><given-names>M.</given-names></name><name name-style="western"><surname>McKenna</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gaffney</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ridgway</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Boran</surname><given-names>G.</given-names></name><name name-style="western"><surname>Conlon</surname><given-names>K.C.</given-names></name></person-group><article-title>An Association Between Abnormal Bone Turnover, Systemic Inflammation, and Osteoporosis in Patients With Chronic Pancreatitis: A Case-Matched Study</article-title><source>Am. J. Gastroenterol.</source><year>2015</year><volume>110</volume><fpage>336</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1038/ajg.2014.430</pub-id><pub-id pub-id-type="pmid">25623657</pub-id></element-citation></ref><ref id="B53-nutrients-17-02720"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Poulsen</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Vestergaard</surname><given-names>P.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name></person-group><article-title>Vitamin-D deficiency in patients with chronic pancreatitis&#8212;Prevalence and pitfalls</article-title><source>Pancreatology</source><year>2017</year><volume>17</volume><fpage>22</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2016.10.007</pub-id><pub-id pub-id-type="pmid">28029611</pub-id></element-citation></ref><ref id="B54-nutrients-17-02720"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arvanitakis</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ockenga</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bezmarevic</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gianotti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Krznari&#263;</surname><given-names>&#381;.</given-names></name><name name-style="western"><surname>Lobo</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>L&#246;ser</surname><given-names>C.</given-names></name><name name-style="western"><surname>Madl</surname><given-names>C.</given-names></name><name name-style="western"><surname>Meier</surname><given-names>R.</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>M.</given-names></name><etal/></person-group><article-title>ESPEN guideline on clinical nutrition in acute and chronic pancreatitis</article-title><source>Clin. Nutr.</source><year>2020</year><volume>39</volume><fpage>612</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1016/j.clnu.2020.01.004</pub-id><pub-id pub-id-type="pmid">32008871</pub-id></element-citation></ref><ref id="B55-nutrients-17-02720"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanakis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vipperla</surname><given-names>K.</given-names></name><name name-style="western"><surname>Papachristou</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>Brand</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Slivka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Whitcomb</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>D.</given-names></name></person-group><article-title>Bone health assessment in clinical practice is infrequenty performed in patients with chronic pancreatitis</article-title><source>Pancreatology</source><year>2020</year><volume>20</volume><fpage>1109</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2020.07.396</pub-id><pub-id pub-id-type="pmid">32826169</pub-id><pub-id pub-id-type="pmcid">PMC9148534</pub-id></element-citation></ref><ref id="B56-nutrients-17-02720"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bang</surname><given-names>U.C.</given-names></name><name name-style="western"><surname>Benfield</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bendtsen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Hyldstrup</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>J.B.</given-names></name></person-group><article-title>The Risk of Fractures Among Patients With Cirrhosis or Chronic Pancreatitis</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2014</year><volume>12</volume><fpage>320</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2013.04.031</pub-id><pub-id pub-id-type="pmid">23644391</pub-id></element-citation></ref><ref id="B57-nutrients-17-02720"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Traini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Piciucchi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Signoretti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Arcidiacono</surname><given-names>P.G.</given-names></name></person-group><article-title>Exocrine pancreatic insufficiency: Prevalence, diagnosis, and management</article-title><source>Clin. Exp. Gastroenterol.</source><year>2019</year><volume>12</volume><fpage>129</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.2147/CEG.S168266</pub-id><pub-id pub-id-type="pmid">30962702</pub-id><pub-id pub-id-type="pmcid">PMC6432881</pub-id></element-citation></ref><ref id="B58-nutrients-17-02720"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dom&#237;nguez&#8211;Mu&#241;oz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Iglesias&#8211;Garc&#237;a</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vilari&#241;o&#8211;Insua</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iglesias&#8211;Rey</surname><given-names>M.</given-names></name></person-group><article-title>13C-Mixed Triglyceride Breath Test to Assess Oral Enzyme Substitution Therapy in Patients With Chronic Pancreatitis</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2007</year><volume>5</volume><fpage>484</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2007.01.004</pub-id><pub-id pub-id-type="pmid">17445754</pub-id></element-citation></ref><ref id="B59-nutrients-17-02720"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leeds</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Oppong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>D.S.</given-names></name></person-group><article-title>The role of fecal elastase-1 in detecting exocrine pancreatic disease</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2011</year><volume>8</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2011.91</pub-id><pub-id pub-id-type="pmid">21629239</pub-id></element-citation></ref><ref id="B60-nutrients-17-02720"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De-Madaria</surname><given-names>E.</given-names></name><name name-style="western"><surname>Abad-Gonz&#225;lez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aparicio</surname><given-names>J.</given-names></name><name name-style="western"><surname>Aparisi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Boadas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Boix</surname><given-names>E.</given-names></name><name name-style="western"><surname>De-Las-Heras</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dom&#237;nguez-Mu&#241;oz</surname><given-names>E.</given-names></name><name name-style="western"><surname>Farr&#233;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Fern&#225;ndez-Cruz</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The Spanish Pancreatic Club&#8217;s recommendations for the diagnosis and treatment of chronic pancreatitis: Part 2 (treatment)</article-title><source>Pancreatology</source><year>2013</year><volume>13</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2012.11.310</pub-id><pub-id pub-id-type="pmid">23395565</pub-id></element-citation></ref><ref id="B61-nutrients-17-02720"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frulloni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Falconi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gabbrielli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gaia</surname><given-names>E.</given-names></name><name name-style="western"><surname>Graziani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pezzilli</surname><given-names>R.</given-names></name><name name-style="western"><surname>Uomo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Andriulli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balzano</surname><given-names>G.</given-names></name><name name-style="western"><surname>Benini</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Italian consensus guidelines for chronic pancreatitis</article-title><source>Dig. Liver Dis.</source><year>2010</year><volume>42</volume><fpage>S381</fpage><lpage>S406</lpage><pub-id pub-id-type="doi">10.1016/S1590-8658(10)60682-2</pub-id><pub-id pub-id-type="pmid">21078490</pub-id></element-citation></ref><ref id="B62-nutrients-17-02720"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jalal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Hopper</surname><given-names>A.D.</given-names></name></person-group><article-title>Practical guide to the management of chronic pancreatitis</article-title><source>Front. Gastroenterol.</source><year>2019</year><volume>10</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1136/flgastro-2018-101071</pub-id><pub-id pub-id-type="pmcid">PMC6583580</pub-id><pub-id pub-id-type="pmid">31288255</pub-id></element-citation></ref><ref id="B63-nutrients-17-02720"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duggan</surname><given-names>S.</given-names></name><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feehan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ridgway</surname><given-names>P.</given-names></name><name name-style="western"><surname>Conlon</surname><given-names>K.</given-names></name></person-group><article-title>Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: A review</article-title><source>Nutr. Clin. Pract.</source><year>2010</year><volume>25</volume><fpage>362</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1177/0884533610373772</pub-id><pub-id pub-id-type="pmid">20702842</pub-id></element-citation></ref><ref id="B64-nutrients-17-02720"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;BRien</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Omer</surname><given-names>E.</given-names></name></person-group><article-title>Chronic Pancreatitis and Nutrition Therapy</article-title><source>Nutr. Clin. Pract.</source><year>2019</year><volume>34</volume><fpage>S13</fpage><lpage>S26</lpage><pub-id pub-id-type="doi">10.1002/ncp.10379</pub-id><pub-id pub-id-type="pmid">31535736</pub-id></element-citation></ref><ref id="B65-nutrients-17-02720"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ito</surname><given-names>T.</given-names></name><name name-style="western"><surname>Irisawa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ohtsuka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ohara</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kanno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kida</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sakagami</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sata</surname><given-names>N.</given-names></name><name name-style="western"><surname>Takeyama</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Evidence-based clinical practice guidelines for chronic pancreatitis 2021</article-title><source>J. Gastroenterol.</source><year>2022</year><volume>57</volume><fpage>709</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1007/s00535-022-01911-6</pub-id><pub-id pub-id-type="pmid">35994093</pub-id><pub-id pub-id-type="pmcid">PMC9522716</pub-id></element-citation></ref><ref id="B66-nutrients-17-02720"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikeura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Takaoka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Uchida</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miyoshi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Okazaki</surname><given-names>K.</given-names></name></person-group><article-title>Beneficial Effect of Low-Fat Elemental Diet Therapy on Pain in Chronic Pancreatitis</article-title><source>Int. J. Chronic Dis.</source><year>2014</year><volume>2014</volume><fpage>862091</fpage><pub-id pub-id-type="doi">10.1155/2014/862091</pub-id><pub-id pub-id-type="pmid">26464866</pub-id><pub-id pub-id-type="pmcid">PMC4590936</pub-id></element-citation></ref><ref id="B67-nutrients-17-02720"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shea</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Bishop</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Gelrud</surname><given-names>A.</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>S.D.</given-names></name></person-group><article-title>An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis</article-title><source>Pancreatology</source><year>2003</year><volume>3</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1159/000069144</pub-id><pub-id pub-id-type="pmid">12649562</pub-id></element-citation></ref><ref id="B68-nutrients-17-02720"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rasmussen</surname><given-names>H.H.</given-names></name><name name-style="western"><surname>Irtun</surname><given-names>&#216;.</given-names></name><name name-style="western"><surname>Olesen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Drewes</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Holst</surname><given-names>M.</given-names></name></person-group><article-title>Nutrition in chronic pancreatitis</article-title><source>World J. Gastroenterol. WJG</source><year>2013</year><volume>19</volume><fpage>7267</fpage><lpage>7275</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i42.7267</pub-id><pub-id pub-id-type="pmid">24259957</pub-id><pub-id pub-id-type="pmcid">PMC3831208</pub-id></element-citation></ref><ref id="B69-nutrients-17-02720"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gon&#231;alves</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Capela</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Cotter</surname><given-names>J.</given-names></name></person-group><article-title>Nutrition in Pancreatic Diseases: A Roadmap for the Gastroenterologist</article-title><source>GE Port. J. Gastroenterol.</source><year>2024</year><volume>31</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1159/000530835</pub-id><pub-id pub-id-type="pmid">38314032</pub-id><pub-id pub-id-type="pmcid">PMC10836866</pub-id></element-citation></ref><ref id="B70-nutrients-17-02720"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Hlasko</surname><given-names>J.</given-names></name></person-group><article-title>Dietary fiber in pancreatic disease: Effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes</article-title><source>Am. J. Clin. Nutr.</source><year>1985</year><volume>41</volume><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1093/ajcn/41.3.517</pub-id><pub-id pub-id-type="pmid">2579539</pub-id></element-citation></ref><ref id="B71-nutrients-17-02720"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stigliano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Waldthaler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Martinez-Moneo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lionetto</surname><given-names>L.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Malvik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hedstrom</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kaczka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scholdei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haas</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Vitamins D and K as Factors Associated with Osteopathy in Chronic Pancreatitis: A Prospective Multicentre Study (P-BONE Study)</article-title><source>Clin. Transl. Gastroenterol.</source><year>2018</year><volume>9</volume><fpage>e197</fpage><pub-id pub-id-type="doi">10.1038/s41424-018-0066-8</pub-id><pub-id pub-id-type="pmcid">PMC6189068</pub-id><pub-id pub-id-type="pmid">30323223</pub-id></element-citation></ref><ref id="B72-nutrients-17-02720"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mart&#237;nez-Moneo</surname><given-names>E.</given-names></name><name name-style="western"><surname>Stigliano</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hedstr&#246;m</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kaczka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Malvik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Waldthaler</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maisonneuve</surname><given-names>P.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>P.</given-names></name><name name-style="western"><surname>Capurso</surname><given-names>G.</given-names></name></person-group><article-title>Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis</article-title><source>Pancreatology</source><year>2016</year><volume>16</volume><fpage>988</fpage><lpage>994</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2016.09.008</pub-id><pub-id pub-id-type="pmid">27681502</pub-id></element-citation></ref><ref id="B73-nutrients-17-02720"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sikkens</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Cahen</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Braat</surname><given-names>H.</given-names></name><name name-style="western"><surname>Poley</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Kuipers</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>M.J.</given-names></name></person-group><article-title>The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis</article-title><source>Pancreatology</source><year>2013</year><volume>13</volume><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2013.02.008</pub-id><pub-id pub-id-type="pmid">23719594</pub-id></element-citation></ref><ref id="B74-nutrients-17-02720"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Struyvenberg</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>S.D.</given-names></name></person-group><article-title>Practical guide to exocrine pancreatic insufficiency&#8212;Breaking the myths</article-title><source>BMC Med.</source><year>2017</year><volume>15</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-017-0783-y</pub-id><pub-id pub-id-type="pmid">28183317</pub-id><pub-id pub-id-type="pmcid">PMC5301368</pub-id></element-citation></ref><ref id="B75-nutrients-17-02720"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindkvist</surname><given-names>B.</given-names></name><name name-style="western"><surname>Dom&#237;nguez-Mu&#241;oz</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Luaces-Regueira</surname><given-names>M.</given-names></name><name name-style="western"><surname>Casti&#241;eiras-Alvari&#241;o</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nieto-Garcia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Iglesias-Garcia</surname><given-names>J.</given-names></name></person-group><article-title>Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis</article-title><source>Pancreatology</source><year>2012</year><volume>12</volume><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2012.04.006</pub-id><pub-id pub-id-type="pmid">22898630</pub-id></element-citation></ref><ref id="B76-nutrients-17-02720"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Midha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>Y.K.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>P.K.</given-names></name></person-group><article-title>Dietary Counseling Versus Dietary Supplements for Malnutrition in Chronic Pancreatitis: A Randomized Controlled Trial</article-title><source>Clin. Gastroenterol. Hepatol.</source><year>2008</year><volume>6</volume><fpage>353</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.cgh.2007.12.040</pub-id><pub-id pub-id-type="pmid">18328440</pub-id></element-citation></ref><ref id="B77-nutrients-17-02720"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mavilakandy</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oyebola</surname><given-names>T.</given-names></name><name name-style="western"><surname>Boyce</surname><given-names>R.</given-names></name><name name-style="western"><surname>Noble</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kamel</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Buccheri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Nancarrow</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bhardwaj</surname><given-names>N.</given-names></name><name name-style="western"><surname>Garcea</surname><given-names>G.</given-names></name></person-group><article-title>Pilot study examining the impact of a specialist multidisciplinary team clinic for patients with chronic pancreatitis</article-title><source>Pancreatology</source><year>2020</year><volume>20</volume><fpage>1661</fpage><lpage>1666</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2020.10.041</pub-id><pub-id pub-id-type="pmid">33109470</pub-id></element-citation></ref><ref id="B78-nutrients-17-02720"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haj-Mirzaian</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>B.N.</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Zaheer</surname><given-names>A.</given-names></name></person-group><article-title>Value of multidisciplinary collaboration in acute and chronic pancreatitis</article-title><source>Abdom. Radiol.</source><year>2020</year><volume>45</volume><fpage>1458</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1007/s00261-019-02320-9</pub-id><pub-id pub-id-type="pmid">31748821</pub-id></element-citation></ref><ref id="B79-nutrients-17-02720"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrik</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Trikudanathan</surname><given-names>G.</given-names></name></person-group><article-title>Multidisciplinary Care for Adults with Chronic Pancreatitis: Incorporating Psychological Therapies to Optimize Outcomes</article-title><source>Pancreas</source><year>2022</year><volume>51</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000001953</pub-id><pub-id pub-id-type="pmid">35195589</pub-id></element-citation></ref><ref id="B80-nutrients-17-02720"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitcomb</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Buchner</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Forsmark</surname><given-names>C.E.</given-names></name></person-group><article-title>AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review</article-title><source>Gastroenterology</source><year>2023</year><volume>165</volume><fpage>1292</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2023.07.007</pub-id><pub-id pub-id-type="pmid">37737818</pub-id></element-citation></ref><ref id="B81-nutrients-17-02720"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindkvist</surname><given-names>B.</given-names></name></person-group><article-title>Diagnosis and treatment of pancreatic exocrine insufficiency</article-title><source>World J. Gastroenterol.</source><year>2013</year><volume>19</volume><fpage>7258</fpage><lpage>7266</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i42.7258</pub-id><pub-id pub-id-type="pmid">24259956</pub-id><pub-id pub-id-type="pmcid">PMC3831207</pub-id></element-citation></ref><ref id="B82-nutrients-17-02720"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>C.</given-names></name><name name-style="western"><surname>Thieroff-Ekerdt</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shiff</surname><given-names>S.</given-names></name><name name-style="western"><surname>Magnus</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gommoll</surname><given-names>C.</given-names></name></person-group><article-title>Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis</article-title><source>J. Cyst. Fibros.</source><year>2016</year><volume>15</volume><fpage>675</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.jcf.2016.02.010</pub-id><pub-id pub-id-type="pmid">27013382</pub-id></element-citation></ref><ref id="B83-nutrients-17-02720"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martyniak</surname><given-names>A.</given-names></name><name name-style="western"><surname>W&#243;jcicka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rogatko</surname><given-names>I.</given-names></name><name name-style="western"><surname>Piskorz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tomasik</surname><given-names>P.J.</given-names></name></person-group><article-title>A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth</article-title><source>Microorganisms</source><year>2025</year><volume>13</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms13010057</pub-id><pub-id pub-id-type="pmid">39858825</pub-id><pub-id pub-id-type="pmcid">PMC11768010</pub-id></element-citation></ref><ref id="B84-nutrients-17-02720"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>dos Santos</surname><given-names>P.Q.</given-names></name><name name-style="western"><surname>Guedes</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>de Jesus</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>dos Santos</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Fiaconne</surname><given-names>R.L.</given-names></name></person-group><article-title>Effects of using symbiotics in the clinical nutritional evolution of patients with chronic pancreatitis: Study prospective, randomized, controlled, double blind</article-title><source>Clin. Nutr. ESPEN</source><year>2017</year><volume>18</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.clnesp.2017.01.005</pub-id><pub-id pub-id-type="pmid">29132740</pub-id></element-citation></ref><ref id="B85-nutrients-17-02720"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Park</surname><given-names>W.G.</given-names></name></person-group><article-title>PPI and PERT for Exocrine Pancreatic Insufficiency&#8212;Pertinent or Problem?</article-title><source>Dig Dis. Sci.</source><year>2025</year><volume>70</volume><fpage>1288</fpage><lpage>1289</lpage><pub-id pub-id-type="doi">10.1007/s10620-025-08932-0</pub-id><pub-id pub-id-type="pmid">39984786</pub-id></element-citation></ref><ref id="B86-nutrients-17-02720"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sander-Struckmeier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Beckmann</surname><given-names>K.</given-names></name><name name-style="western"><surname>Janssen-van Solingen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pollack</surname><given-names>P.</given-names></name></person-group><article-title>Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON<sup>&#174;</sup>) in patients with pancreatic exocrine insufficiency</article-title><source>Pancreas</source><year>2013</year><volume>42</volume><fpage>983</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1097/MPA.0b013e31828784ef</pub-id><pub-id pub-id-type="pmid">23587850</pub-id></element-citation></ref><ref id="B87-nutrients-17-02720"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Targownik</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Saini</surname><given-names>S.D.</given-names></name></person-group><article-title>AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review</article-title><source>Gastroenterology</source><year>2022</year><volume>162</volume><fpage>1334</fpage><lpage>1342</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2021.12.247</pub-id><pub-id pub-id-type="pmid">35183361</pub-id></element-citation></ref><ref id="B88-nutrients-17-02720"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dominguez-Munoz</surname><given-names>J.E.</given-names></name></person-group><article-title>Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts</article-title><source>Gut</source><year>2006</year><volume>55</volume><fpage>1056</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1136/gut.2006.094912</pub-id><pub-id pub-id-type="pmcid">PMC1856339</pub-id><pub-id pub-id-type="pmid">16766768</pub-id></element-citation></ref><ref id="B89-nutrients-17-02720"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mioc</surname><given-names>J.</given-names></name><name name-style="western"><surname>O&#8217;dOnovan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Henry</surname><given-names>O.</given-names></name></person-group><article-title>Clinical Efficacy and Safety of Treatments for Exocrine Pancreatic Insufficiency: A Systematic Literature Review</article-title><source>Digestion</source><year>2025</year><volume>106</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1159/000541326</pub-id><pub-id pub-id-type="pmid">39299226</pub-id><pub-id pub-id-type="pmcid">PMC11825132</pub-id></element-citation></ref><ref id="B90-nutrients-17-02720"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferrone</surname><given-names>M.</given-names></name><name name-style="western"><surname>Raimondo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Scolapio</surname><given-names>J.S.</given-names></name></person-group><article-title>Pancreatic enzyme pharmacotherapy</article-title><source>Pharmacotherapy</source><year>2007</year><volume>27</volume><fpage>910</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1592/phco.27.6.910</pub-id><pub-id pub-id-type="pmid">17542772</pub-id></element-citation></ref><ref id="B91-nutrients-17-02720"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caliari</surname><given-names>S.</given-names></name><name name-style="western"><surname>Benini</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sembenini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gregori</surname><given-names>B.</given-names></name><name name-style="western"><surname>Carnielli</surname><given-names>V.</given-names></name><name name-style="western"><surname>Vantini</surname><given-names>I.</given-names></name></person-group><article-title>Medium-Chain Triglyceride Absorption in Patients with Pancreatic Insufficiency</article-title><source>Scand. J. Gastroenterol.</source><year>1996</year><volume>31</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3109/00365529609031633</pub-id><pub-id pub-id-type="pmid">8927947</pub-id></element-citation></ref><ref id="B92-nutrients-17-02720"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;KEefe</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rolniak</surname><given-names>S.</given-names></name><name name-style="western"><surname>Raina</surname><given-names>A.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hegazi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Centa-Wagner</surname><given-names>P.</given-names></name></person-group><article-title>Enteral feeding patients with gastric outlet obstruction</article-title><source>Nutr. Clin. Pract.</source><year>2012</year><volume>27</volume><fpage>76</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1177/0884533611432935</pub-id><pub-id pub-id-type="pmid">22307492</pub-id></element-citation></ref><ref id="B93-nutrients-17-02720"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parrish</surname><given-names>C.R.</given-names></name></person-group><article-title>Pancreatic Exocrine Insufficiency and Enteral Feeding: A Practical Guide with Case Studies</article-title><source>Nutr. Issues Gastroenterol.</source><year>2018</year><volume>XLII</volume><fpage>62</fpage><lpage>74</lpage></element-citation></ref><ref id="B94-nutrients-17-02720"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirtallo</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Forbes</surname><given-names>A.</given-names></name><name name-style="western"><surname>McClave</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Waitzberg</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>A.R.</given-names></name><collab>International Consensus Guideline Committee Pancreatitis Task Force</collab></person-group><article-title>International consensus guidelines for nutrition therapy in pancreatitis</article-title><source>J. Parenter. Enter. Nutr.</source><year>2012</year><volume>36</volume><fpage>284</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1177/0148607112440823</pub-id><pub-id pub-id-type="pmid">22457421</pub-id></element-citation></ref><ref id="B95-nutrients-17-02720"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D.</given-names></name></person-group><article-title>New Insights into Chronic Pancreatitis: Potential Mechanisms Related to Probiotics</article-title><source>Microorganisms</source><year>2024</year><volume>12</volume><elocation-id>1760</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms12091760</pub-id><pub-id pub-id-type="pmid">39338435</pub-id><pub-id pub-id-type="pmcid">PMC11434092</pub-id></element-citation></ref><ref id="B96-nutrients-17-02720"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pagliari</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saviano</surname><given-names>A.</given-names></name><name name-style="western"><surname>Newton</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Serricchio</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Lago</surname><given-names>A.A.D.</given-names></name><name name-style="western"><surname>Gasbarrini</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cianci</surname><given-names>R.</given-names></name></person-group><article-title>Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders</article-title><source>Mediat. Inflamm.</source><year>2018</year><volume>2018</volume><fpage>7946431</fpage><pub-id pub-id-type="doi">10.1155/2018/7946431</pub-id><pub-id pub-id-type="pmid">29563853</pub-id><pub-id pub-id-type="pmcid">PMC5833470</pub-id></element-citation></ref><ref id="B97-nutrients-17-02720"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pimentel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Saad</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Long</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S.S.C.</given-names></name></person-group><article-title>ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth</article-title><source>Am. J. Gastroenterol.</source><year>2020</year><volume>115</volume><fpage>165</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.14309/ajg.0000000000000501</pub-id><pub-id pub-id-type="pmid">32023228</pub-id></element-citation></ref><ref id="B98-nutrients-17-02720"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rammohan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sathyanesan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rajendran</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pitchaimuthu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Perumal</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Balaraman</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>R.</given-names></name><name name-style="western"><surname>Palaniappan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Govindan</surname><given-names>M.</given-names></name></person-group><article-title>Synbiotics in surgery for chronic pancreatitis: Are they truly effective?: A single-blind prospective randomized control trial</article-title><source>Ann. Surg.</source><year>2015</year><volume>262</volume><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1097/SLA.0000000000001077</pub-id><pub-id pub-id-type="pmid">25575262</pub-id></element-citation></ref><ref id="B99-nutrients-17-02720"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boicean</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ichim</surname><given-names>C.</given-names></name><name name-style="western"><surname>Todor</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Anderco</surname><given-names>P.</given-names></name><name name-style="western"><surname>Popa</surname><given-names>M.L.</given-names></name></person-group><article-title>The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders</article-title><source>Diagnostics</source><year>2024</year><volume>14</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics14090861</pub-id><pub-id pub-id-type="pmid">38732276</pub-id><pub-id pub-id-type="pmcid">PMC11082979</pub-id></element-citation></ref><ref id="B100-nutrients-17-02720"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosendahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>B&#246;deker</surname><given-names>H.</given-names></name><name name-style="western"><surname>M&#246;ssner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Teich</surname><given-names>N.</given-names></name></person-group><article-title>Hereditary chronic pancreatitis</article-title><source>Orphanet J. Rare Dis.</source><year>2007</year><volume>2</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1750-1172-2-1</pub-id><pub-id pub-id-type="pmid">17204147</pub-id><pub-id pub-id-type="pmcid">PMC1774562</pub-id></element-citation></ref><ref id="B101-nutrients-17-02720"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hegyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>P&#225;rniczky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lerch</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Sheel</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Rebours</surname><given-names>V.</given-names></name><name name-style="western"><surname>Forsmark</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Del Chiaro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rosendahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>De-Madaria</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sz&#252;cs</surname><given-names>&#193;.</given-names></name><etal/></person-group><article-title>International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club</article-title><source>Pancreatology</source><year>2020</year><volume>20</volume><fpage>579</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2020.03.014</pub-id><pub-id pub-id-type="pmid">32376198</pub-id></element-citation></ref><ref id="B102-nutrients-17-02720"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKay</surname><given-names>I.R.</given-names></name><name name-style="western"><surname>Ooi</surname><given-names>C.Y.</given-names></name></person-group><article-title>The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review</article-title><source>Front. Pediatr.</source><year>2022</year><volume>10</volume><elocation-id>914790</elocation-id><pub-id pub-id-type="doi">10.3389/fped.2022.914790</pub-id><pub-id pub-id-type="pmid">35832587</pub-id><pub-id pub-id-type="pmcid">PMC9271761</pub-id></element-citation></ref><ref id="B103-nutrients-17-02720"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Widdern</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Rosendahl</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ammer-Herrmenau</surname><given-names>C.</given-names></name></person-group><article-title>Chronic and Idiopathic Pancreatitis&#8212;A Personalized Treatment Approach</article-title><source>United Eur. Gastroenterol. J.</source><year>2024</year><volume>13</volume><fpage>116</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1002/ueg2.12741</pub-id><pub-id pub-id-type="pmid">39704081</pub-id><pub-id pub-id-type="pmcid">PMC11866313</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="nutrients-17-02720-t001" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02720-t001_Table 1</object-id><label>Table 1</label><caption><p>Multifactorial drivers of malnutrition in chronic pancreatitis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reduced Oral Intake</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Maldigestion E Malabsorption</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hypercatabolism E Metabolic Dysfunctions</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Postprandial abdominal pain<break/>Nausea and vomiting<break/>Early satiety and bloating<break/>Neuro-hormonal anorexia (CCK, GLP-1, leptin)<break/>Depression or anxiety interfering with diet<break/>Voluntary food restriction to avoid pain<break/>Diabetic gastroparesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exocrine pancreatic insufficiency<break/>Acidic duodenal pH &#8594; bile-salt precipitation<break/>Steatorrhoea with loss of ADEK vitamins<break/>Small-intestinal bacterial overgrowth (SIBO) and dysbiosis<break/>Biliary or duodenal strictures causing stasis<break/>Dilated or obstructed pancreatic duct with stones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic low-grade inflammation (IL-6, TNF-&#945;)<break/>Pancreatogenic diabetes with insulin and glucagon deficiency &#8594; proteolysis<break/>Oxidative stress and systemic catabolism<break/>Accelerated skeletal-muscle breakdown &#8594; sarcopenia<break/>Micronutrient-driven endocrine disruption (vitamins D and K)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nutrients-17-02720-t002" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02720-t002_Table 2</object-id><label>Table 2</label><caption><p>Laboratory and radiologic signatures of chronic pancreatitis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biochemical Markers</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Typical Imaging Findings</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8595; Faecal elastase-1<break/>&#8595; Serum trypsinogen<break/>&#8595; Fat-soluble vitamins A, D, E, K<break/>&#8595; 25-OH-vitamin D &#177;<break/>&#8595; Ca<sup>2+</sup> &amp; &#8593; PTH<break/>&#8595; Albumin, pre-albumin<break/>&#8595; Mg, Zn, Se<break/>&#8595; Vitamin B12<break/>&#8593; Homocysteine<break/>&#8593; HbA1c / fasting glucose<break/>&#8595; C-peptide (type 3c DM)<break/>&#8593; CRP, ESR; &#8593; IL-6, TNF-&#945;<break/>&#8595; Phase angle on BIA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CT/MRI/MRCP &#8594; duct &#8220;chain-of-lakes&#8221;, coarse calcifications, gland atrophy, pseudocysts/WON<break/>CE-CT/CTA &#8594; vascular events (splenic- or portal-vein thrombosis, pseudoaneurysm)<break/>EUS &#8594; hyperechoic foci and strands, lobularity, duct wall thickening and alternating strictures/sacculations, intraductal stones, cysts<break/>Ultrasound &#8594; ductal dilatation, parenchymal calcifications, cystic lesions<break/>DXA &#8594; low BMD<break/>CT body composition/MRI-PDFF &#8594; visceral fat loss, &#8595; skeletal muscle area</td></tr></tbody></table><table-wrap-foot><fn><p>Symbols: &#8595; = decreased/low; &#8593; = increased/high;</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="nutrients-17-02720-t003" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02720-t003_Table 3</object-id><label>Table 3</label><caption><p>General dietary recommendations in chronic pancreatitis with nutritional deficits.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Dietary Aspects</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Recommendations</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caloric intake</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High-energy intake (~30&#8211;35 kcal/kg) to be adjusted over time. <break/>Monitor intake via food records. <break/>Best if dietary counselling is present.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aim for ~1.2&#8211;1.5 g/kg/day to preserve lean mass.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fat intake</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~25&#8211;35% of calories from fat if PERT is effective. <break/>Fat-free diets are not recommended.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carbohydrates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Complex carbohydrates are preferred over simple sugars to maximise energy intake. <break/>Special attention to glycaemic control in type 3c diabetes.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fibres</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avoid very high-fibre foods.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Meal pattern</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Small, frequent meals (5&#8211;6 per day) and <break/>Avoid large-volume meals. <break/>Avoid skipping meals to avoid hypoglycaemia.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pain triggers</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avoid personal trigger foods. <break/>Strict alcohol and tobacco avoidance.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Micronutrients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regularly screen for and supplement deficiencies: vitamins A/D/E/K, calcium, magnesium, and zinc.<break/>Do not supplement vitamins blindly.<break/>Also screen for water-soluble vitamins and supplement if deficient. </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Multidisciplinary team </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">It is best to create a multidisciplinary team to treat the nutritional deficiencies, especially in severe cases.<break/>Assess and address psychosocial problems.<break/>Address substance abuse and dietary adherence barriers.</td></tr></tbody></table></table-wrap><table-wrap position="float" id="nutrients-17-02720-t004" orientation="portrait"><object-id pub-id-type="pii">nutrients-17-02720-t004_Table 4</object-id><label>Table 4</label><caption><p>Summary of key studies on the role and management of malnutrition in chronic pancreatitis of the last 10 years.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study (Author, Year)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Size</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Findings</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Implication</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rammohan et al., 2015 [<xref rid="B98-nutrients-17-02720" ref-type="bibr">98</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients undergoing surgery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Probiotics reduced postoperative infections and shortened hospital stays (effect estimates not extracted here).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Consider targeted perioperative microbiome modulation to reduce postoperative morbidity after pancreatic drainage procedures.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hoogenboom et al., 2016 [<xref rid="B50-nutrients-17-02720" ref-type="bibr">50</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review and meta-analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients and healthy controls (HC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 studies (465 CP, 378 HC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High prevalence of vitamin D deficiency/insufficiency in CP, not clearly higher than HC across pooled studies.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Routine screening for hypovitaminosis D in CP is justified even if excess risk vs. HC is inconsistent.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mart&#237;nez-Moneo et al., 2016 [<xref rid="B72-nutrients-17-02720" ref-type="bibr">72</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review and meta-analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 studies (548 CP)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fat-soluble vitamin deficiencies are common in CP.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic assessment and replacement of fat-soluble vitamins should be embedded in CP care pathways.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Olesen et al., 2017 [<xref rid="B32-nutrients-17-02720" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort prospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP international registry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">910 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High prevalence of EPI and pancreatogenic diabetes (type 3c) within registry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic screening for EPI and type 3c diabetes is warranted in CP.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dos Santos et al., 2017 [<xref rid="B84-nutrients-17-02720" ref-type="bibr">84</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RCT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Symbiotics improved clinical symptoms and laboratory indices versus control.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adjunctive symbiotics may benefit selected CP patients with EPI.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vanga et al., 2018 [<xref rid="B38-nutrients-17-02720" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review and meta-analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients with and without EPI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 studies (1101 patients)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FE-1 demonstrated high sensitivity and specificity for moderate&#8211;severe EPI compared with the secretin test.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FE-1 is an appropriate first-line, non-invasive test for clinically significant EPI.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Olesen et al., 2019 [<xref rid="B48-nutrients-17-02720" ref-type="bibr">48</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective cohort</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">182 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sarcopenia occurred even with normal BMI and predicted hospitalisations and lower survival.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Body composition assessment adds prognostic information beyond BMI in CP.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kempeneers et al., 2020 [<xref rid="B33-nutrients-17-02720" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cohort prospective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP national registry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">987 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPI prevalence rose from ~20% at 5 years to ~70% at 20 years; alcoholic aetiology is associated with higher risk.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Longer disease duration and alcoholic CP identify patients at high risk for EPI.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phillips et al., 2022 [<xref rid="B43-nutrients-17-02720" ref-type="bibr">43</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 studies (420 CP patients)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral nutrition support and counselling improved BMI and overall nutritional status.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Structured nutrition programmes confer measurable benefit and should be implemented.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gopi et al., 2022 [<xref rid="B44-nutrients-17-02720" ref-type="bibr">44</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">297 CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Approximately half of CP patients met GLIM criteria for malnutrition.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Applying GLIM systematically identifies a high burden of malnutrition in CP.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vujasinovic et al., 2023 [<xref rid="B25-nutrients-17-02720" ref-type="bibr">25</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retrospective cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Autoimmune CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100 AIP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Micronutrient deficiencies remained common despite PERT.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PERT alone may be insufficient; targeted micronutrient monitoring/repletion is required.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ramai et al., 2023 [<xref rid="B49-nutrients-17-02720" ref-type="bibr">49</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review and meta-analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 studies (1659 CP)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Osteoporosis/osteopenia are prevalent and underscreened in CP.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bone health assessment should be incorporated into routine CP care.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Khurmatullina et al., 2025 [<xref rid="B4-nutrients-17-02720" ref-type="bibr">4</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review and meta-analysis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP patients vs. HC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 studies (1556 CP)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sarcopenia prevalence is significantly higher in CP than in controls.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High sarcopenia burden supports routine body composition and functional assessment.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chu et al., 2025 [<xref rid="B89-nutrients-17-02720" ref-type="bibr">89</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Systematic review</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CP with EPI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28 studies</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PERT improves fat absorption and stool quality; evidence is insufficient to compare specific formulations.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PERT is efficacious for EPI in CP; formulation selection can be individualised pending comparative data.</td></tr></tbody></table><table-wrap-foot><fn><p>CP Chronic Pancreatitis; RCT Randomised Controlled Trial; HC Healthy Controls; EPI = Exocrine Pancreatic Insufficiency; BMI = Body Mass Index; GLIM = Global Leadership Initiative on Malnutrition; PERT = Pancreatic Enzyme Replacement Therapy; AIP = Autoimmune Pancreatitis.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>